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Abstract
The process through which new blood vessels are formed within the body is known
as angiogenesis. An essential part of our survival, it has also been implicated more
recently in many diseases both in terms of induced growth, and abnormal vascular
structure.
Angiogenesis is characterized as two processes, the development of a vascular
network during embryonic growth and the production of new blood vessels. This
work focuses on the latter, and seeks to develop a robust, three-dimensional model
for simulating blood vessel growth and the attendant processes of blood ﬂow and
mass transfer within the simulated system. A system was developed which utilises
medical imaging scan data (speciﬁcally, MicroCT) as the initial conditions from
which a network of vessels is grown. This is combined with GPU accelerated
simulations of ﬂuid dynamics, with the intention of providing a technique for future
use in predictive medicine and therapeutic simulation.
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Chapter 1
Introduction
Angiogenesis is the formation of new blood vessels in the human body. With on-
going research, evidence continues to mount up to implicate vascular structure
and function, in particular the angiogenic process, in a long list of human dis-
eases. This includes cancer, diabetes, cardiovascular diseases, and in recent years
neurodegenerative diseases [1], [2]. Study of the formation of microvasculature,
therefore, has important implications in diagnosis and treatment of diseases. It
is no surprise, then, that recent years have seen an increase in research into the
mechanisms behind the angiogenic process, as well as attempts to predict how
various therapies aﬀect it.
Simulations of angiogenesis in two dimensions are fairly common now, with the
model developed by Anderson and Chaplain [3] being of particular note. These
models are designed to replicate growth patterns observed in vitro; thus, their ap-
plication is limited in real-world situations. Continued interest in vascular growth
in cancer, in particular, has resulted in interest in simulations of the eﬀectiveness
of anti-angiogenic therapy [4] as well as chemotherapy [5].
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This thesis describes how a CPU-based Cellular Potts model [6] of sprouting
angiogenesis in three dimensions is combined with medical imaging techniques
and ﬂuid dynamics equations to create an individual-based GPU accelerated an-
giogenesis simulation. The use of the GPU, optimized for fast, highly parallel
mathematical operations, provides an increase in simulation speed and balances
resource requirements across hardware. Primarily, this work is concerned with
modelling vascular growth at the microscopic level. It is becoming clearer that the
structure and function of microvasculature, that is the smallest vessels within the
human body, are implied in many diseases. However, the need for studying mi-
crovasculature is not limited to clinical diagnosis of disease. In tissue engineering,
creating vascularized tissue is a considerable problem, limiting the size to which
eﬀective engineered tissues can be grown [7].
The system described here attempts to personalise simulations of angiogenesis
using medical scan data. Speciﬁcally, microCT scans of resin cast rat cerebral
vasculature are segmented to remove reconstruction artifacts and imported to in-
stantiate nascent endothelial cells in a homogeneous three-dimensional grid repre-
senting the area over which the simulation is performed. A growth factor source is
added, and simulation of steady production and diﬀusion of the vascular endothe-
lial growth factor (VEGF) is performed on the GPU using the NVidia Compute
Uniﬁed Device Architecture (CUDA) programming platform. Motion of individ-
ual endothelial cells is then tracked over the lifetime of the simulation towards the
source of growth factor, incorporating sprouting and anastamosis (looping) events.
The network generated is used for simulations of blood ﬂow and mass transfer, also
accelerated using graphics hardware.
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1.1 Angiogenesis in health and diseases
Since the discovery of angiogenesis, research has continued to highlight the role
of this process in disease, from implications of vascular abnomalies in Diabetic
Retinopathy [8], Cardiovascular Diseases [9], Alzheimer’s Disease[10], through to
the uncontrolled angiogenic response initiated by tumors in cancer patients [1].
1.1.1 Mechanisms of angiogenesis
Angiogenesis is triggered by the release of angiogenic factors, such as Fibroblast
Growth Factors, a family of proteins which stimulate ﬁbroblast and endothelial
cell growth. The binding of angiogenic factors to receptors in endothelial cells
stimulates the cells into migrating towards the source of the factor. The cells are
induced to release enzymes, which degrades the basement membrane of the parent
vessel, thus enabling them to move towards the source of the growth factor.
Angiogenesis occurs in multiple stages. Sprouts are formed as cells migrate
towards the source of the growth factor, led by the tip cell, which recruits more
endothelial cells from the parent vessel. As the tip moves, the sprout has a ten-
dency to split, thus creating the well-known branching structure associated with
the vasculature.
From time to time, migrating sprouts come into contact with other sprouts
and can join with them to form the characteristic looping of the microvascula-
ture. These events are known as anastamoses and are a key factor of the vascular
geometry, enabling bi-directional ﬂow of blood through the system.
During embryo growth and development, the network of vasculature develops
from a ﬁeld of endothelial cells, during which the cells group together to form
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the primitive vascular network which later develops into the functional systems
our bodies rely upon. This process is also known as vasculogenesis. In developed
bodies, however, angiogenesis occurs during wound healing in a process known as
neoangiogensis. This form of angiogenesis is preceded by the release of chemical
factors by the body when in need of vascularisation, for example when areas of the
body exist in a hypoxic state. Of the triggers of neoangiogenesis, the most common
are chemical factors released by various parts of the body. Initially isolated in the
1970s from tumor mass [11], new factors have been identiﬁed since then. Of note
is Vascular Endothelial Growth Factor (VEGF), identiﬁed as a key element in the
mechanism of tumor-induced angiogenesis [12].
1.1.2 Angiogenesis in cancer
The risk of developing some form of cancer of a lifetime is currently rated on average
to be approximately 40%, or a 2 in 5 chance. This means that the majority of
people will experience cancer either through developing it, or having a friend or
relative who does. The chances of said cancer being fatal are 1 in 5, and it is
estimated that more than 1.6 million new cases of cancer will be diagnosed in the
US alone, with nearly 600 000 deaths, in 2014 [13].
Angiogenesis is of key interest in the study and treatment of cancer. Initially,
tumors in the body are unable to grow to sizes greater than one or two cubic mil-
limetres, a size limited by the diﬀusion limits of oxygen within the body. Tumors
which outgrow this size begin to die on the inside as they are unable to secure
adequate nutrients. However, if a tumor switches to the angiogenic phenotype
the cells begin to secret angiogenic factors, such as VEGF. As these factors move
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through the surrounding tissue, they encounter existing blood vessels and encour-
age the growth of new vasculature towards the tumor, thus securing a nutrient
supply and creating the possibility of metastatis - in some cases, tumor cells can
detatch and enter the bloodstream, spreading the cancer across the body, often
with fatal consequences.
1.1.3 Anti-angiogenic therapy
Anti-angiogenic therapies are an area of recent interest in terms of treating cancer,
particularly in malignant glioma where angiogenesis is considered to be the key
event in tumor progression [14]. Recent evidence has shown that antiangiogenic
therapy can work to normalize tumor vasculature (i.e. making it more regular and
eﬃcient) which in turn causes a more eﬀective platform for targeted cytotoxic ther-
apies such as chemo- and radiotherapy, both of which require adequate functional
vasculature to maintain eﬃcacy [15]. However, application of antiangiogenics car-
ries an inherent risk since giving to high a dose can lead to destruction of too
much of the tumor vasculature, making cytotoxic therapies ineﬀective and lead-
ing to toxicity in normal tissues. Anti-angiogenic therapy has shown promise in
terms of reducing the abilities of tumours to initiate vasculaturization, however re-
cent research has shown that tumors can become resistant to the therapy through
upregulation of alternative pro-angiogenic signals [16]. As such, anti-angiogenic
therapies as they stand provide a respite, but not a cure.
Modelling of such therapies is of key interest in the continuing struggle against
cancer. Arakelyan et al [4] developed a numerical model which was comprised of
a set of formulae describing each of the interactions in their system. The results
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were in the form of numerical values of measured quantities, such as growth factor,
tumor size, eﬀective vascular density and mature vessel density.
Ledzewicz et al [17] used a numerical method to solve a mathematical de-
scription of cancer treatment, that is solving for a maximum reduction in tumour
volume, to provide dosages of anti-angiogenic drugs. More recently, Stefanini et al
[18] detailed a model of VEGF distribution and interactions in tissue with the goal
of aiding in the design of optimal strategies for VEGF inhibition. This is purely
a numerical model which represents the tissue as a collection of concentrations.
Similarly, Ledzewicz et al [17] used a numerical method to solve a mathematical
description of cancer treatment, solving for a maximum reduction in tumor vol-
ume, to provide dosage sizes of anti-angiogenic drugs. Benzekry et al [19] used a
similar method to model the eﬀectiveness of combining anti-angiogenic therapies
with cytotoxic therapies. This model focuses primarily on the eﬀect of the delay
between treatment types, rather than the dose given, and is concerned with opti-
mizing this. It explicitly states, however ,that this is a model in which parameters
would need to be adjusted to a particular patient.
Also of note is the model developed by Owen et al [5], a two-dimensional grid-
based model for simulation of combining chemotherapy with a macrophage-based
gene therapy under inﬂuence of a magnetic ﬁeld, alongside a vessel and tumor
growth system. While not an antiangiogenic model, it uses a similar approach to
generate and simulate the vascular growth and drug movement, primarily through
expression of VEGF. The model is based on a regular grid, across which drug and
oxygen concentrations are stored for each cell in the grid.
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1.1.4 Angiogenesis in neurodegenerative diseases
Our research interest in the microvasculature was brought upon by a new direc-
tion in research of Alzheimer’s Disease (AD). This is based on a new theory on the
aetiology of AD - the neurovascular pathway to neurodegeneration. Amyloid beta
(ABeta) deposition in the walls of cerebral blood vessels had generally been at-
tributed to the cause and development of AD. A growing body of evidence suggests
that there is a strong association between the structure of the cerebral vasculature
and AD, especially the microvasculature/capillaries that are responsible for the
exchange of nutrients across the blood-brain barrier. This raises the possibility
that the abnormalities in the structure may be a decisive early indicator of de-
mentia. There is also evidence that vascular changes occur early in the course
of the disease, and may even precede ABeta deposition. Studies on the brains
of mice show that before ABeta and other symptoms of AD appear, these mice
already have altered cerebral vasculature. In fact, abnormal (e.g. holed, kinked
or distorted) microvascular networks in AD brains at the arteriole, capillary, and
venule level were reported a long time ago and there was no diﬀerence between
relatively large arteries in AD and normal brains, but it is only in recent years
that the neurovascular factor has become the focus of research into AD. Similarly,
the neurovascular factor in other neurological diseases such as Multiple Sclerosis
(MS) have been receiving much interest in recent years as many MS patients have
been found to have vascular abnormalities. Thus the cerebral vasculature may be
a target for diagnosis and treatment of these neurological diseases.
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1.2 Angiogenesis in tissue engineering
In their 2011 paper [7], Novosel et al. describe the challenge of vascularization
in tissue engineering as the key limitation in engineering large tissue structures.
In vivo, tissues are supplied with nutrients via naturally formed vascular systems,
but in vitro tissues are generally submerged in a nutrient ﬂuid. Typically, the
maximum distance between capillary vessels in vivo is 200µm, which correlates
with the diﬀusion limit of oxygen, however some tissues such as skin and cartilage
are able to perfuse from a greater distance without dying, and hence these tissues
are typically the result of tissue engineering eﬀorts. There are two main approaches
to vascularizing tissues: cell-based strategies and scaﬀold-based strategies. The
former is based on the ability of endothelial cells to form new vessels, the latter
on the actual vessels themselves.
1.2.1 Cell-based vascularization
Cell-based strategies for tissue vascularization rely on the twin processes of neoan-
giogenesis and vasculogenesis. Within this particular subset of methods are two
main strategies of encouraging the growth of functional vasculature, prevascular-
ization and induction of neoangiogenesis. The former deals with growing a vascular
network within the engineered tissue before implantation. The latter involves us-
ing chemical growth factors to encourage neoangiogenesis once the tissue has been
placed in situ.
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1.2.2 Scaffold-based strategies
While still limited in its clinical applications, building artiﬁcial vasculature is an
area of continuing research. Scaﬀolds can be either biological in nature, derived
from decellularized mammalian sections, or artiﬁcial in nature, using directed de-
sign of vasculature-like structures. Decellularized sections reveal natural 3D vas-
cular structures; the matrix can then be seeded with human cells, introducing
the possibility of building perfusable constructs. In artiﬁcial approaches, scaﬀolds
are typically produced from hydrogels, made of either biopolymers or synthetic
polymers [7]. Even more recently, modiﬁed three-dimensional printing techniques
have been utilized to create a framework of a sugar-based substance which, when
hardened, is submerged in a matrix substance and seeded with cells. The frame-
work is dissolved, revealing a network of tubular structures which can be used
as a vascular system with which to perfuse an engineered tissue structure [20].
While initially limited to a cuboid structure, this raises interesting implications
regarding the applicability of designing eﬃcient vascular structures for arbitrary
three-dimensional volumes.
In their 2009 paper, Lafayette et al [21] described their method of designing
vascular scaﬀolds through reconstruction of micro-CT data. This process involves
perfusing the vasculature with a resin to produce a cast, scanning the cast at high
resolution, reconstructing and segmenting the images acquired, and then correcting
errors manually with a CAD software program. The advantage to this method is
that it provides a naturally formed, functional vascular structure, which can be
re-used since essentially a “pattern” is created. The disadvantage to this method
is that the structure obtained is designed for a singular purpose, and of a ﬁxed
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shape. Therefore, a more ﬂexible method of scaﬀold design would be desirable.
1.3 Challenges of vascular modelling
In silico simulations of biological processes present complex challenges to re-
searchers. First and foremost is the complexity of the biological process being
simulated. Even simple processes within the body are comprised of many con-
stituent mechanisms, each subtly tuned to each other. Identifying these mecha-
nisms requires an in depth knowledge of the body on a microscopic level.
Because of the complexity inherent in such systems, the need for computing
resources is very high. It is of paramount importance that a simulation of a
biological system can run in reasonable time. This is especially important when
developing a model, since parameters may need to be modiﬁed repeatedly in order
to adjust the model to accurately reﬂect real biological processes. While the term
reasonable time can mean diﬀerent things in diﬀerent situations, in context of the
possible need to repeat the simulation multiple times, reasonable time is considered
here to be anything between ten minutes and two hours.
Typically, simulations of biological processes have been limited to a two-dimensional
domain. These simulations are often based on observations of in vitro experiments,
where cell movements are sometimes constrained to two dimensions, such as cell
migration within a petri dish, and often in a uniform environment. Such a sim-
ulation is not an appropriate indicator of biological processes in vivo, where the
domain is three-dimensional and variable.
This research has been performed in a three-dimensional domain. Such an
increase in dimensions has had the eﬀect of causing an exponential increase in
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complexity. Consider the immediate neighborhood of a single cell in a regular
grid: in two dimensions, this neighborhood is eight other cells ( 32 − 1 ); in three
dimensions, however, this is increased to twenty-six ( 33−1 ), more than three times
as many. Applying this increase in complexity to each element causes simulation
resource requirements to increase by an order of magnitude.
The nature of a biological system can be described as a collection of individual
agents with diﬀering roles, the emergent behaviour being that which we observe
as life. This work focuses on one particular system, the growth of microvascula-
ture, and thus the agents in question are endothelial cells. Around this are several
physical and molecular phenomena, such as blood ﬂow and respiration, reactions
or sub-systems which all contribute to the overall function of the system. The
relevance of this is the applicability of GPGPU (General Purpose Graphics Pro-
cessing Unit) hardware to such a system, as the parallel nature of computation on
a GPGPU device is ideal for simulations of complex systems. Having the GPU as
a candidate for such simulations gives a possible method for spreading the load
across all available hardware resources.
An alternative mode of parallel computing is that of grid computing, and bears
mentioning at this point. Grid computing involves sharing the resources of multiple
distinct computers, sometimes distributed geographically, communicating via a
network. This gives the immediate beneﬁt of being very easily scalable, with
the potential of a huge amount of processing power being dedicated to a single
task. However, this comes with the increased overhead of data transfer between
machines, and increased cost involved in both the initial investment and running
costs. A GPU solution mitigates both the cost and data transfer issues, while
sacriﬁcing overall power. It is important to note, as well, that grid computing
17
is typically for computationally more complex tasks utilizing the CPU, although
more recently GPU grids have been used [22]. An attractive middle-ground could
be found in the ability to combine multiple graphics cards in a single machine,
through the use of such technology as NVidia’s SLI bridge [23].
1.4 Thesis roadmap
The rest of the thesis is organised as follows. Chapter 2 provides background to
the thesis, introducing the key concepts in computerised modelling of angiogensis,
and simulating blood ﬂow. Chapter 3 introduces cloud computing and medical
imaging, in particular an application of the former using the latter. Chapter 4
describes in detail the angiogenesis model developed during the course of this
work. Chapter 5 describes the blood ﬂow and diﬀusion simulation work of the
thesis; Chapter 6 details how these were implemented using parallel processing on
the GPU. Chapter 7 explains how individual vasculature from microCT images are
integrated with the modelling and simulation frameworks to form a personalised
simulation system. Chapter 8 comes back to cloud computing in the context of a
modular analysis framework, work completed in the ﬁrst year of the project, and
how the model described in previous chapters can be implemented as a unique
analysis module. Conclusions and future work are given in Chapter 9.1.
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Chapter 2
Literature review
2.1 Modelling angiogenesis
In the past decades, considerable eﬀort has been made in the development of
mathematical models of angiogenesis [18, 24, 25]. Mathematical models rely on
the phenomenon of hypoxic regions of tissue producing growth factors, which then
diﬀuse across the tissue towards existing vessels causing endothelial cell migration
and the creation of de novo vasculature. This is often combined with hydrody-
namic models to assess the eﬀectiveness of the vasculature, and direct remodelling
eﬀorts. These models rely on a partially stochastic process, which can produce
ineﬃcient or unrealistic results, and are generally bound to a discrete grid result-
ing in sharp corners. While such attempts to ’grow’ simulated vascular networks
in silico have been the most popular approach, some eﬀorts have been made to
generate vasculature following tree-based or fractal methods. This has, however,
had limited success.
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2.1.1 Anderson and Chaplain’s model
Anderson and Chaplain [3] developed a model based on motion of migrating en-
dothelial tip cells governed by three functions; the chemotactic function, or ten-
dency to climb a growth factor gradient; the haptotactic function, relating to the
requirement of ﬁbronectin; and cell motion.
Motion of migrating endothelial tip cells is deﬁned as a partial diﬀerential
equation with three key components as follows:
∂n
∂t
= Dn∇
2n− χ∇ · (n∇c)− ρ∇ · (n∇f) (2.1)
where χ represents a function of the angiogenic factor (VEGF-A) density c, ρ
represents a function of ﬁbronectin density f , and Dn represents a random-walk
component, based on endothelial cell density n .
In this system, the function chi represents uptake and binding of the angiogenic
factor, and is described as follows:
∂c
∂t
= −λnc (2.2)
where λ is a positive constant. Finally, uptake and binding/degradation of
ﬁbronectin, the function rho, is modelled as:
∂f
∂t
= ωn− µnf (2.3)
where ω and µ are both positive constants [3].
This system of equations was then solved using ﬁnite diﬀerence methods to
provide a discretization of the model which could be applied to a regular grid de-
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scribing a unit square (i.e. a numerical domain of [0, 1] × [0, 1]) representing an
area of width 2mm. The square was divided into a grid of 200 x 200 cells, oﬀering
a resolution of 0.01mm per unit. This system was expanded to include random
branching events and looping due to fusion of cells which met (anastomosis). Sim-
ulation eﬀorts were shown to give results visually comparable to those of in vivo
experiments.
This led the way for further improvements and modiﬁcations of the scheme
and blood ﬂow modelling using ﬂuid dynamics. Arakelyan et al [4] developed a
numerical model for tumor vasculature which was comprised of a set of formulae
describing each of the interactions in their system. The results were in the form
of numerical values of measured quantities including growth factor density, tu-
mour size, eﬀective vascular density, concentration of pericytes, and mature vessel
density. Their model suggested that the joint administration of two agents, an
anti-angiogenic agent and an anti-maturation agent, provided prolonged suppres-
sion of tumour growth and a decrease in average tumour size, irrespective of initial
conditions.
Preziosi and Astanin showed a model of vasculogenesis and angiogenesis which
created realistic models of vascular networks, comparable to real networks [26].
Linninger and Vaicaitis showed examples of artiﬁcially generated cerebral vascular
trees based on actual patient data which show similarity to the real images [27].
The model incorporates natural ﬂow laws to generate trees with high congruence
to actual vasculature in terms of appearance and statistical properties. Moore and
David developed a method for modelling the autoregulation function of the cerebral
vasculature in such a way as to simulate the eﬀects of stenosis and occlusion [28].
Perfahl et al developed a multiscale model of angiogenesis in tumours in three
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dimensions, which was shown to be able to predict the spatio-temporal evolution
of vascular tumours [29].
Maturation of vessels is an important factor in the growth of blood vessels
which relates to the formation and regression of mature vessels, (that is, vessels
which have stabilized). Previous models have focused mainly on the formation
of immature vessels (here categorized as angiogenesis). The model developed by
Arakelyan et al [4] includes the concept of vessel maturation, however the algo-
rithm is described numerically in terms of more abstract concepts such as eﬀective
vascular volume and concentration of pericytes. As such, its application is less
direct in terms of predicting vascular growth initiated by tumor presence.
Godde and Kurtz [30] developed a model which works on a hexagonal grid
and considers shear-stress and pressure dependent systems. Their model showed
that shear-stress dependent modelling led to a more homogeneous distribution of
capillaries connecting terminal arterial and venous vessels than that of pressure
dependent modelling. Owen et al. [31] developed a multi-scale model of angiogen-
esis and vascular remodelling which accounts for vessel pruning due to low wall
shear stress amongst other factors.
A model of VEGF distribution and interactions in tissue was developed by
Stefanini et al [18] which was designed to aid in determining optimal strategies
for VEGF inhibition. The model describes kinetic ligand-receptor interactions be-
tween VEGF isoforms (VEGF121, VEGF165) and ECM binding sites for VEGF165.
The model does not explicitly describe tissue geometry, but rather represents the
components of the tissue (capillaries, ECs, basement membranes) as numerical
values of concentrations of molecular species.
Watson et al. [25] developed a model of vascular development in the murine
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retinal plexus during neonatal development, involving modelling development of
the astrocyte network which precedes vasculogenesis in neonatal mice. This ap-
proach employs similar modelling techniques to those outlined by Anderson and
Chaplain in [3] by tracking individual astrocyte and endothelial tip cells. How-
ever, this model adds increased complexity through remodelling of vasculature.
This involves simulation of blood ﬂow through the network, and delivery of oxy-
gen to surrounding tissue as a result, followed by pruning of the capillary network
in light of relevant criteria. Simulation is started at embryonic day ﬁfteen (E15),
with an initial seeding of astrocyte cells around the location of the optic nerve.
These cells grow outward, encouraged by an existing gradient of platelet-derived
growth factor A (PDGF-A), a factor implicated in the development of astrocyte
networks. Hypoxic astrocytes are modeled as producing VEGF-A; thus, as the as-
trocyte network grows, a gradient of VEGF-A is created across the retina. At the
day of birth (E21.5) endothelial cells are seeded around the optic nerve and begin
to migrate radially outward, motivated by the recently created VEGF-A gradient.
2.1.2 Other modelling approaches
Cellular Automata
An alternative to the typically developed models is that of a cellular automaton
model for angiogenic processes. In a cellular automaton a region is, typically,
divided into a regular grid, each of which constitutes one cell in the automaton.
Each cell is assigned a state, and the state of each cell is derived iteratively from
itself and its neighbors. Rules are established to determine whether a cell changes
state after each iteration. Possibly the most well known cellular automaton is
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Conway’s Game of Life [32], in which a cell can be either alive or dead. Evolution of
the system is described by three rules; if a cell has fewer than two living neighbors,
or more than three living neighbours, it dies; if a cell has two or three living
neighbors, it survives; if a dead cell has three living neighbours, it is brought
to life [33]. Through this simple model, immensely complex systems have been
designed, and it continues to be a subject of study today.
Topa [34] demonstrated a cellular automaton model developed to simulate tu-
mor induced angiogenesis, emulating the results of Anderson and Chaplain’s [3]
model. The results, whilst comparable to those of Anderson and Chaplain, are
in no way an improvement to the model, and thus considerable work would be
required to improve this model to the point where it could be of any use. The
model described is, in fact, a hybrid model based upon the concept of a cellular
automaton; the automaton model is used to simulate the tissue and distribution of
nutrients and other chemicals throughout, with the vessel network being a graph-
based representation which sits atop the tissue automaton.
Tree-based networks
Comparisons between human vasculature and tree structures are often made. In
fact, one of the processes crucial to formation of a vascular network in a developing
embryo is known as intussusceptive arborization [35], that is formation of a branch-
ing structure (arbor meaning tree, a word whose origin is, curiously, unknown).
Thus, it is reasonable to assume that tree systems could be used to generate vi-
sually similar structures to in vivo observations of human vasculature. The use of
tree structures is attractive, as they appear to be a more eﬃcient way of regularly
ﬁlling a space than a vessel growth algorithm. Tree generation algorithms have
24
problems of their own, however. For one, they do not form anastamoses (looping
structures), an essential characteristic of functional vasculature.
Space-ﬁlling trees are deserving of consideration when regarding the idea of
ﬁlling an arbitrary space with vasculature [36]. Space-ﬁlling trees can be regular
or random, and involve subdividing a space and branching into the new subdivi-
sions from the nearest node. Regular trees ﬁll the space in a symmetrical fashion,
which leads to the property of having a short maximum distance from one node
to the base node. Rapidly-exploring Random Trees are created from an already
fully subdivided space. From a base node, a random point in the space is chosen
and connected to the nearest node. This process is continued until the space is
ﬁlled [37]. One problem with this initial model of formation is that the tree has a
tendency to cross itself (see ﬁgure 2.1), which would result in low-eﬃciency of vas-
culature. Similarly, it does little in the way of emulating real vascular structures.
In order to improve this, some considerations can be taken into account.
Figure 2.1: A Rapidly-exploring Random Tree at 100, 200, 500 and 1000 iterations.
Initially, the decision-making process behind choosing a new node to branch
into can be modiﬁed to use only a region close to existing nodes. This eﬀectively
limits the size of each branch to a pre-deﬁned maximum length. With appropriate
conditions, this should eﬀectively remove the possibility of self-crossing branches.
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Second, the system can be modiﬁed to take into account a map of perfused areas,
limiting the tree to branching only into areas of low oxygen content. Thus the
process becomes more akin to biological growth in that it is driven by biological
factors.
In considering tissue scaﬀold development, the idea of a space-ﬁlling tree is an
appealing one. Possibly the largest barrier to engineering large tissue structures is
the diﬀusion capability of oxygen. This diﬀusion characteristic limits the distance
between vascular segments to a maximum of 200µm (0.2mm) [7], thus limiting
the size of an engineered tissue quite severely without an eﬀective vascular system
in place. A space-ﬁlling tree appeals through its ability to ﬁll an arbitrary space
up to a desired threshold, for instance minimizing the distance between adjacent
branch elements.
Unlike other models of angiogenesis, this approach does not model movements
of individual cells, but instead attempts to imitate the formation of a vascular net-
work by the assessment of various factors, such as oxygen diﬀusion level. Rapidly-
exploring random trees were initially developed as a path planning tool, thus devel-
opment of an RRT model of scaﬀold design could be considered a chemodynamic
(that is, led by chemical factors) path-planning problem of sorts. In kinodynamic
RRT development, a single location is given as a goal, and once a path to that goal
is acquired the tree is considered complete [37]. In order to use a tree generation
system for production of vascular scaﬀolds, the ’goal’ would be two-fold: a) the
space must be ﬁlled such that all vascular tree branches are a maximum of 200µm
from any other branch, b) the the structure must produce a ﬂow throughout the
scaﬀold, presumably bridging the gap between opposing sides of the structure.
Like other trees, however, rapidly-exploring random trees do not taking looping
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and blood ﬂow into account, and thus are not a complete substitution for a vascular
tree. Bearing this in mind, a possible solution would be to grow two opposing trees
from opposite ends of the domain, and allow them to join where interactions occur.
The advantage of this approach is the speed with which it could be generated since
the decision making process is on a per branch basis, not per cell.
2.2 Simulating blood flow
As long ago as 1830 the movement blood in microvessels was of interest to sci-
entists. The French physicist and physiologist Poiseuille took it upon himself to
investigate the problem of resistance to blood ﬂow posed by the narrowest parts
of the vascular system. His work on the ﬂow of liquids such as water and blood
through narrow tubes led to him describing what is now known as Poiseuille’s law
(Eq 6.3). He noted that pressure across a tube was directly proportional to the
length and radius of the tube, and the viscosity and ﬂow-rate of the liquid within,
and more speciﬁcally that it related to the fourth power of the radius.
For the next century, or so, Poisueille’s law was generally considered the gospel
for blood vessels. In 1954 the Microcirculatory Society was formed with the no-
tion, in part, of promoting research into the form and function of microcirculation
in health and disease. At this time, relatively little was known of the rheological
behaviour of blood within microvessels [38], until the pioneering work of Fåhræus
and Lidqvist discovered the curious eﬀect of reducing capillary diameter on the
relative viscosity of blood. Blood is a concentrated suspension of red blood cells
in plasma [39], typically comprised of approximately 40-45% red blood cells (ery-
throcytes). A single red blood cell is, normally, a biconcave disc with a diameter
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Figure 2.2: Red blood cells traveling in larger vessels are able to maintain their
ordinary shape (a), however when passing through vessels smaller than the normal
size of a single red blood cell, they are stressed in order to ﬁt, forming a shape
more akin to that of a bullet (b).
of 8 µm and a thickness of 2µm. During ﬂow through the microvasculature, this
is stressed to form a more bullet-like shape [39] by the smaller diameter of the
capillaries themselves (Figure 2.2).
Fåhræus and Lidqvist reasoned that blood would not necessarily act like an
ordinary ﬂuid when passing through the smallest of human blood vessels, and
thus began to investigate the eﬀect of reduced vessel width on the viscosity of
blood. In their experiments they were able to simulate blood ﬂow through tubes
of much narrower diameter than Poiseuille ever was, with values as low as 0.05mm.
They discovered that at these decreasing widths, below approximate 0.3mm, the
viscosity of blood appeared to decrease [40]. This phenomenon was termed the
Farhæus-Lindqvist eﬀect. Unfortunately, like Poiseuille, Farhæus and Lindqvist
were limited by their equipment, and were unable to investigate anything smaller.
If they had, they would have discovered something even more strange.
Pries et al. took this research further, and studied in vivo the eﬀect of microves-
sels in the rat mesentery (a membrane which attaches many internal organs to the
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abdominal wall), the results of which were observed through intravital microscopy.
Pries et al. discovered that at radii of below approximately 20µm (0.02mm), there
was a sharp increase in the apparent viscosity of blood moving through them.
From their experimental data they were able to develop an equation, which they
termed the “in vivo viscosity law” [41], describing the relative apparent viscosity
of blood within these vessels.
More recently, computational ﬂuid dynamics have evolved to be able to simulate
complex ﬂow patterns in non-uniform environments. Lattice Boltzmann (LB)
methods have been used by many as an accurate method for simulating blood ﬂow
in vessels reconstructed from medical images. Due to the nature of the method,
LB is able to accurately simulate ﬂuid movement on a small scale, resulting in
accurate representation of the ﬂow of blood for such applications.
Lattice Boltzmann methods work by subdividing the simulation volume into
a regular, axially aligned grid of nodes, each representing an area in the volume.
Each node is aﬀected by all of its neighbors, and similarly has an eﬀect on each of its
neighbors. In this way, the Lattice Boltzmann is a discretisation of the Boltzmann
equation in three dimensions. When simulating ﬂow in a vascular network, the
grid created for a LB simulation is created by ﬁlling the convex space created by
the shape of the vascular network. The resultant grid is updated by calculating
the eﬀect that each element has on each neighboring element, and the state that
leaves the element in.
The advantage of this method is that it accurately simulates the ﬂow of liquid
within volumes of an arbitrary shape, and takes the shape into account when
performing the simulation. However, microvasculature requires special concerns
when being simulated, since the nature of blood on such a small scale is not that
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of a uniform ﬂuid. When considering blood on a macroscopic scale, it is easy
to consider it as a uniform ﬂuid, but in reality it consists of several constituent
parts, including red blood cells (erythroctyes), white blood cells, and plasma. In
humans, blood has a typical haematocrit, that is the percentage of red blood cells,
of between forty and forty-ﬁve percent. So let us consider the eﬀect this has on
the movement of blood within the microvasculature.
Red blood cells are typically 8µm across, whereas the microvessels can be as
small as 5µm in diameter. The result of this is that red blood cells are deformed
as they travel through the vessels. With this consideration in mind, let us now
consider the Lattice Boltzmann method of ﬂuid simulation for such vessels. When
traveling through capillaries red blood cells are deformed, but also lubricated by a
thin layer of plasma on the vessel wall. This, then, is already a non-uniform ﬂuid
that is being considered. We must also consider that the elements of the grid which
represent blood cells and those which represent plasma are undiﬀerentiated, even
though they have diﬀerent physical properties. For example, the elements which
represent a part of a blood cell should be physically connected to other elements
representing another part of the same cell. As such, LB methods are unable to
simulate the movement and deformation of red blood cells within capillaries. The
assumption of uniformity on such a small scale combined with the high level of
computational complexity suggests that a Lattice Boltzmann method would be a
poor choice for simulations of blood ﬂow on this scale.
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Chapter 3
Cloud medical imaging and
visualisation
The work detailed in this section was completed in the ﬁrst year of study, in col-
laboration with Biotronics3D on their cloud-based medical imaging system 3DNet
Medical. The work centers around the development of a medical imaging analysis
platform, developed within a proprietary cloud-based 3D medical imaging solu-
tion. While focused primarily on the creation of the modular framework within
the cloud system, it initially involved some work on volume rendering with the in-
tention of providing a fully-featured SDK based on the core of the 3DNet rendering
software. The result was a method for rendering depth values to an image based
on the raycasting volume rending algorithm. The aim of the industrial project was
initially categorized in two parts as follows:
1. To create a ﬂexible modular framework for medical image analysis within a
cloud environment.
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2. To prove the framework by creating an analysis module with clinical rele-
vance which can be integrated through use of the framework.
This chapter introduces concepts in cloud computing, medical imaging and
volume rendering, as a basis for the ﬁrst part. The second is covered later, in
chapter 8.
3.1 Cloud computing
The concept of cloud computing has become commonplace in modern computer
science. Ubiquitous are the adverts which claim that data is safer “in the cloud”,
or that business processes can be much improved by moving them “to the cloud”.
Of course, such a broad deﬁnition of cloud computing does little to demystify the
term for the average user, and obscures the truth of the underlying technology
involved.
In its simplest form, cloud computing can be described as moving functionality
away from desktop computers and onto remote machines. The essence of a cloud is
to have a collection of machines running as a cluster, oﬀering an on-demand service
which users are able to interact with from their personal computers via an internet
connection. A useful example of this technology would be cloud-based storage
solutions, which allow users to create documents and take photos, among other
actions, and store them on a remote cloud. These become available for retrieval
later on any of a number of devices tied to a particular user account. Services are
typically made available through native applications on the operating system, as
well as through a web interface. To the end user this seamless interaction with one
or a number of other computers results in the appearance of functionality beyond
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the scope of which their device is physically capable.
This ability to extend the use of a device beyond its capability is the primary
motivation behind the development of medical imaging applications which use
cloud computing. Typically, medical imaging applications require a high powered
computer to be able to run, and as such having many capable machines is often
prohibitively expensive. Being able to perform highly complex operations within
a cloud computing system is a useful advancement; the provision of such services
is usually subscription-based, under what is called the Software As A Service
(SAAS) model. SAAS moves away from software being a commodity, where each
user would own a copy, to a service provided by a company under a pay-to-use
model, be it on a per-use basis, or on a regular billing (subscription) system.
Volume rendering is the method in which projections of 3D volumes are dis-
played as 2D images. Early implementations of volume rendering techniques fo-
cused on rendering of texture data, initially as a set of blended 2D textures and
later, as the hardware permitted, utilising 3D textures, before ray casting was im-
plemented. In medical imaging, a data set is comprised of a series of images which
are the result of a patient scan. These images are of either cross-sectional slices of
the patient’s entire body, or a sub-section thereof. Traditionally, these sets of data
are viewed as single images, often as a set of consecutive slices. However, a single
study can comprise of as many as thousand images, resulting in more than 1.5
gigabytes of data. Because of this diﬃculties can arise when processing scans on a
slice by slice basis. The use of volumes is therefore desirable. By assigning a thick-
ness to each slice in a scan (which can be determined by the interval at which the
patient was scanned) these slices can be composited to a volume representation of
the patient’s body. This volume can then be used to produce a visualisation of the
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patient with volume rendering. Direct Volume Rendering (DVR) generates images
without the need to create an intermediate polygonal representation of a volume.
Instead, the volume data set is projected onto an image plane. In the image-space
oriented ray casting approaches, rays are cast from the view-point through the
view-plane into the volume. The volume is equidistantly sampled along the ray
and the volume integral is computed by repeated application of the over operator
in front-to-back order. Volume rendering oﬀers a number of challenges, especially
when scaling this to a large multi-user solution such as a cloud. Memory and
processing power are an important consideration. In a cloud environment each
user needs access to enough memory to ensure that the system continues to run
smoothly. A typical study can contain multiple series, of which an average of three
hundred images per series is common. This results in each user requiring, on aver-
age, four gigabytes of memory in order to work. Loading of large data sets takes
time, an issue which needs to be addressed in a cloud system. While processing
power is less of a problem, it is still important to ensure that every user has enough
power to perform the tasks they require. In addition, rendering of large data sets
can take time without an appropriate acceleration structure.
Pure hardware based volume rendering solutions provide real-time performance
and high quality. Consequently they are the most applied approach in practice.
However, pure hardware volume rendering solutions are are limited in their their
functionality as basic visualization systems are supported by hardware volume ren-
dering solutions. Advanced visualization systems provide pre-processing features
such as ﬁltering, segmentation, and morphological operations, among others. If
such operations are not supported by the hardware, they have to be performed
on the CPU and data must be then be transferred back to the hardware. This
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transfer is very time consuming, thus, interactive feedback becomes problematic.
In contrast, within a pure CPU based solution this transfer is unnecessary allow-
ing more eﬃcient processing of data. Furthermore, in the framework of a cloud
environment dedicated hardware-based solutions become prohibitively expensive:
setup cost, maintenance, and even scalability become limited due to hardware
constraints. Thus, a pure CPU based solution is by far the most suitable, and
probably the only truly viable solution, for cloud based rendering.
To accelerate CPU based rendering and image processing, the underlying mem-
ory management has to be modiﬁed. In this case we utilise a bricked memory
layout. Cross-sectional data, e.g. CT and MRI, are large sets of individual images
which combined form a volume in space. Physical memory is typically constructed
in a sequential way, therefore the straightforward approach to loading these images
into memory is to put them one after the other using a linear layout. This layout
has several disadvantages. In a typical set of cross-sectional images, an average 30
percent of the data actually does not contain any useful information. This comes
from the fact that the human body consists of a set of tubular structures (e.g.
arms, legs, and torso). A cross-sectional cut through a tubular structure using
rectangular images does not contain the data well, leaving vast amounts of data
to represent empty space around the body. Furthermore, in the case of advanced
medical imaging application data needs to be processed in a non-sequential, ran-
dom way. Volume ray casting has a strong view-dependent data access pattern,
and consequently, taking a look at the typical cache hierarchy of today’s CPU (L1,
L2, L3) it becomes clear that storing images linearly in memory would cause com-
plete cache thrashing. In order to address the aforementioned issues a signiﬁcant
improvement is gained if the cross-sectional data is arranged in a blocked manner.
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In this case we subdivide and reorganize the entire volume (one 3D-image) into
smaller contiguous lightweight bricks, obtaining a structure analogous to a Rubik’s
cube.
One of the main problems faced when sharing hardware and software resources
between multiple users in an arbitrary manner is the robust and eﬃcient admin-
istration of the hardware available. Not only must each user have secured data
storage and privacy protection, but it must also be able to exploit its resources
without having to directly control how the underlying hardware and software re-
sources are being utilized. Cloud systems are an example of a technology that
requires a managing entity that “virtualizes” the usage of hardware and software
in a way that each user has a direct and transparent interaction with the system.
The challenge is to build a lightweight instrument that allows for a seamless inter-
action eﬃciently. A dual strategy that not only permits automatic virtualization
of the resources but also specializes in distributing them in a coherent manner by
performing a “load balancing” of the tasks on the available resources is required.
Virtualization, as described here, is instrumental to managing secure user ses-
sions and is fundamental to the eﬃcient distributed rendering required to perform
advanced imaging applications. In particular, virtualization is achieved by cre-
ating “sandboxes”, a concept that provides restricted resource sets to individual
users including controlled access to data storage, hardware resources and network-
ing privileges. This creates a local, virtual machine for each user and removes the
burden of requiring them to manage how their tasks are processed by the system.
In order to achieve this securely and eﬃciently, the cloud system is split into
the following sections: a Global Session Manager (GSM) responsible for managing
user speciﬁc session sandboxes, and a View Session Manager (VSM) responsible
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for managing viewing session sandboxes and load-balancing. The load-balancing
itself is done by the Rendering Resource Load Balancer (RRLB), which is part
of the VSM. Both the GSM and VSM are deployed as web services and can be
mirrored for redundancy.
The scalability of the cloud is an important feature, since it inherently implies
a cost eﬀective solution. At any time additional nodes can be added to the cloud
to make it more powerful and the cost per user is much reduced compared to that
of buying individual workstations. Users can be classiﬁed as one of three types;
casual users, who have a low level of activity, active users who have a higher level
of activity, and power users who are using the computationally expensive features
of the system. Whilst a power user may be choosing transformations, transfer
functions, and adjusting settings, casual users could be simply viewing an image
already rendered to the screen. Thus, while a 32-core machine with 64 users would
imply less than a single core per user, in reality this is not the case. It is, in fact,
memory that is the limiting factor, since even those who are not interacting with
the system will use large amounts of memory.
3.2 Medical imaging
Medical imaging covers a broad range of methodologies such as X-Ray imaging,
Magnetic Resonance Imagining (MRI), Positron Emission Tomography (PET),
Computed Axial Tomography (CAT), and many more. It also covers software
such as Patient Archiving and Communication Systems (PACS), and the Digital
Imaging and Communications In Medicine (DICOM) standard [42].
DICOM is the industry standard for the storage and interchange of medical
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images and was put together by the American College of Radiology (ACR) and
the National Electronic Manufacturers Association (NEMA) of America, originally
under the guise of ACR-NEMA. The ﬁrst deﬁnitive version was published in 1985
as ACR-NEMA Standards Publication No. 300-1985, designated version 1.0. This
was followed by two revisions, ﬁrst in 1986, then in 1988, before the standard
was reworked under the guise of DICOM. The purpose of DICOM is to provide
a worldwide standard for the format of medical images and the transfer of such
images between devices, in order to provide a high-level of compatibility between
devices and systems developed by diﬀerent companies.
The Insight Segmentation and Registration Toolkit is an open source toolkit
for the analysis of multi-dimensional images (2D, 3D, nD) provided by the Insight
Software Consortium. ITK is written in C++ with the intention of being cross-
platform, and provides wrappers for other languages such as Java, Python and
Tcl [43]. The Visualization Toolkit (VTK) was similarly developed to provide
common components for developing applications which require the visualization
of 3D graphical elements [44].
These have both been expanded upon in the form of the Medical Imaging
Interaction Toolkit, developed by Wolf et al, initially in 2005 and continuously to
date [45]. The Medical Imaging Interaction Toolkit (MITK) is designed to reduce
the eﬀort involved in developing medical imaging applications which use ITK and
VTK, and as such provides a set of components which use ITK and VTK but oﬀer
further features, such as architecture for easily combining ITK algorithms with
VTK visualization components.
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3.3 Volume rendering
Volume rendering is a method of creating two-dimensional projections of three-
dimensional volumes. Volumes are created by compositing a series of two-dimensional
images taken in parallel planes, such as those of an MRI or CT scan. Images
are assigned a thickness (in the case of medical scans this is determined by the
scan interval) and images are ordered so as to produce a cuboid of voxels (three-
dimensional pixels). This is equivalent to the method used to construct simulation
volumes described in chapter 7.
Early implementations of volume rendering focused on blending texture data,
initially sets of 2D textures and later, as the hardware permitted, 3D textures.
These methods were later superseded by the ray casting algorithm [46]. Due to
advances in the ray casting algorithm oﬀering greatly increased speed, ray casting
is now the standard method for volume rendering in medical imaging applications.
Here, algorithms for texture-based rendering and ray casting will be covered brieﬂy
before discussing the modiﬁcation to the ray casting algorithm for depth rendering.
3.3.1 Texture-based volume rendering
Initially, texture-based volume rendering was performed by blending a set of two-
dimensional textures. These textures are acquired by taking ’slices’ of a volume
parallel to the viewing plane. These textures are then layered in back-to-front or-
der when rendered [46]. Composition of successive color values is performed using
the ’over’ operator, in the following format:
Cfinal = Caαa + (1 - αa)Cbαb
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Figure 3.1: Rays are traced from the viewing plane through the volume and sam-
pled equidistantly. Color values are composited until a predeﬁned opacity thresh-
old is reached.
where Ca, αa, and Cb, αb are the color and alpha (opacity) values of the
fragments to be blended, where b is furthest from the viewing plane.
3.3.2 Ray casting
In ray casting, rays are cast from the view-point through the view-plane into the
volume (Figure 3.1). The volume is equidistantly sampled along the ray and the
volume integral is computed by repeated accumulation of colors and opacities.
At every sampling position a scalar value is interpolated between the corre-
sponding surrounding eight voxels, that is, in the logical three dimensional ex-
tension of a pixel. This value is then classiﬁed according to a transfer function
which maps density values to a colour function. If the sample is non-transparent,
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Figure 3.2: Volume renders of the neck and skull using diﬀerent transfer functions:
(a) shows the entire volume; (b) shows a render containing segmentation informa-
tion where a second transfer function has been applied; (c) displays a combination
display, deﬁned by a planar cut-oﬀ .
a gradient is computed from the surrounding voxels in order to apply shading.
Finally, the sample is composited with the previous samples of the ray. Successive
samples along the ray are calculated until a threshold opacity level is reached, or
the ray exits the volume. Figure 3.2 shows a typical example of a volume ren-
der: (a) shows a render of the full volume; (b) and (c) show renders containing
segmentation information where a second transfer function has been applied.
3.3.3 Rendering depth
In medical imaging applications it can sometimes be desirable to know the depth
of a certain point in a volume render produced. Examples may include the need
to place markers in three-dimensions for alerting colleagues to speciﬁc features of
interest, or for picking a seed point for performing segmentation operations such
as bone removal. To achieve this, the concept of a depth render is created. The
depth render allows existing image generation and transfer protocols to be used to
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convey another layer of information in respect to a volume being rendered.
The depth render algorithm makes use of the existing ray casting algorithm
as a basis, but in this instance does not store color information. The position
the ray is cast from (i.e. a point on the viewing plane) is recorded as an initial
condition for the depth to be calculated. The ray is then cast as normal, and
successive opacity values are accumulated. Once the opacity threshold (deﬁned
by the current transfer function) is reached, the end point of the ray is recorded.
With these two values and some elementary vector mathematics the length of the
ray cast can be calculated, representing the distance of the pixel of interest from
the image plane.
Distances computed this way are stored in an image in the form of pixels. This
takes advantage of the correlation between storing depth values as 32-bit ﬂoating
point numbers and the image format consisting of pixels of four channels of 8 bits
per channel. The distance value is masked into four bytes, which are stored in the
four components of the respective pixel. To retrieve the distance to a particular
pixel, the red, green, blue and alpha values can be recombined to form a 32-bit
ﬂoating point distance value.
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Figure 3.3: The depth render stores 32-bit depth values as colours to make use of
the existing imaging technology.
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Chapter 4
Modelling angiogenesis in three
dimensions
One of the core aims of the work undertaken here was to develop a three-dimensional
model of angiogenesis. Compared with the two-dimensional model developed by
Anderson and Chaplain [3], the extra dimension introduces computational com-
plexity, which has led to the GPU implementation of the ﬂuid dynamics to provide
a mechanism for growth factor diﬀusion within the bounds of the model, and sim-
ulations of blood ﬂow and mass transfer within the vasculature, discussed in detail
in chapter 5. As a whole, the method is a combination of a Cellular Potts model
(CPM), which models cell movement, and partial diﬀerential equations (PDEs),
which are used to govern the release and subsequent diﬀusion of chemical at-
tractants. CPM is a well known lattice-based computational modelling technique
which represents unit sections of an arbitrary space as cells on a grid, updating
them based on a set of probabilistic rules. Typically, within a CPM an object
occupies a single grid location, although they can also occupy multiple grid cells.
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Figure 4.1: Scanned images are thresholded and converted to binary images; these
are then used to instantiate endothelial cells making up the initial environment of
the simulation.
During the initialization step of the simulation, an environment is set up in a
way which reﬂects a section of human physiology. A stack of images acquired from
a microCT scan are imported. The images used are of resin casts of rat cerebral
vasculature, taken at a resolution of 15 µm, approximately the size of an individual
cell. Images are thresholded, resulting in binary images, and individual pixels are
inserted into the domain of the simulation as nascent endothelial cells. Thus,
pixels in the scans are likened to cells within the original vasculature, resulting in
sections of tubular structures from which the neovascularization arises.
To more accurately reﬂect the vasculature these cells represent, before the
simulation begins the domain is scanned for cells which are entirely enclosed -
that is, they have neighbours in both positive and negative directions in all three
axes. Any cell found to match these conditions is ﬂagged for deletion before the
simulation begins. This also has the added eﬀect of reducing the computational
complexity of the system by decreasing the number of agents to simulate. The full
methodology for initialising the environment is discussed in detail in chapter 7.
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Figure 4.2: MicroCT scans of a resin cast of a rat brain show a high level of detail,
and so were an idea candidate as a basis for developing a vascular growth model
through the initial elimination and subsequent simulation of growth of microvas-
culature.
4.1 Endothelial tip cell movement
Typically, models of angiogenesis describe the growth of new vessels from existing
vasculature via tracking the path of migrating endothelial cells. The movement of
these cells is initiated by disruption of the basement membrane which surrounds
the endothelium of existing vessels, thus allowing for free movement of endothelial
cells. Movement is then tracked under the assumption of endothelial cells migrating
towards the source of the growth factor. The equation for endothelial tip cell
motion is deﬁned earlier in section 2.1.1 as equation 2.1.
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Movement of endothelial tip cells is derived from a discretized form of equa-
tion 2.1. Discretization is achieved by applying the ﬁnite diﬀerence method [47]
which yields three equations, relating to each of the components of equation 2.1.
These three equations relate to the three characteristics inﬂuencing cell migration;
movement up a gradient of growth factor, movement up a gradient of ﬁbronectin,
and a random walk component.
Figure 4.3: When a cell moves, the required time for another move is based on
the distance it has travelled, since diagonal moves are further than axially-aligned
ones. The multiplier is based on the length of the movement vector.
Endothelial cells are modelled as agents on the CPU. Each agent is modelled
individually, and thus is aware only of itself and its immediate environment. As
a simpliﬁcation measure, in terms of program structure, a grid (three-dimensional
array) of numerical values is maintained as part of the environment, indicating
whether a particular location within the simulated section is occupied by a cell
or vessel segment. The numerical value is an identiﬁer of the cell which ﬁlled
this space - in the case of a vessel segment, the identity of the originating cell
is given. These values are used to prevent a cell looping into itself, causing early
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termination of the simulation, which sometimes occurs due to the stochastic nature
of cell motion.
When a cell moves, the direction in which it can move is constrained to those
empty cells which are considered to be directly in front of the cell. These cells are
identiﬁed by taking the dot product of the vector from the cell’s current position
and the vector of the direction in which the cell last moved. If the result is
above a threshold value (with normalised vectors a value of 0.5 is used, implying
an angle of less than 90 degrees), the cell is a viable target direction in which
to move. Enabling this constraint removes the possibility of ECs moving in a
direction which would be physically impossible. Deciding in which direction an
endothelial cell moves is performed by distributing probabilities across the set of
cells available for movement. This involves ﬁnding both the cell in the direction
of continued movement and the cell in the direction of the overall chemotactic
gradient. The chemotactic gradient is calculated by summing the diﬀerences of
the growth factor densities across the local environment of the EC:
∑
−1<i<1
−1<j<1
−1<k<1
| χ(i, j, k)− χ(0, 0, 0) | ×(i, j, k) (4.1)
where χ(i, j, k) is the growth factor density at the displacement (i, j, k) from
the ECs location. This yields a vector which is normalized to give χˆ, describing
the direction of the growth factor gradient at the location of the EC. This vector is
used to identify the cell which is in the direction of the chemotactic gradient. The
continued movement cell is simply identiﬁed by repeating the last displacement.
The two cells identiﬁed by the chemical factor gradient and the repetition of the
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Figure 4.4: Cells move towards the source of VEGF (pink), up a density gradient.
Motion is randomised, weighted towards an increase in growth factor density and
in the direction previously moved. Activated tip cells are drawn in blue and have
an additional visualisation element of a vector describing the direction of the local
chemotactic gradient. Red cells are those marked as complete, either through
exclusion or anastamosis.
last move are given weighted probabilities as deﬁned by constants χ and ψ. The
values for these are adjustable by design, such that diﬀerent growth patterns can
be deﬁned, but through repeated simulations values of 0.5 and 0.25 respectively
were found to give the best results.
The remaining cells are assigned an equal portion of 1 - χ - ψ. This represents
the random portion of the movement equation, and is more apparent when the
values for the chemotactic and haptotactic biases are low (see ﬁgure 9.2).
After assigning these probabilities, they are combined to form a distribution
which ranges from 0.0 to 1.0. A random number is generated in this range, and the
cell in whose range this falls is allocated as the location to which the EC moves.
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Figure 4.5: Endothelial cells move towards the source of VEGF up the local density
gradient. The image on the left shows a simulation run with a single source; the
middle image shows the result of deﬁning two sources; the right image contained
no sources, but was initialised with a linear gradient from right to left.
4.2 Vessel formation
When the threshold growth factor density, ν, is reached, nascent endothelial cells
can become activated, allowing them to migrate away from their parent vessel
towards the source of the growth factor. This is the ﬁrst stage in the angiogenic
process, and represents the degradation of the basement membrane caused by the
expression of VEGF under hypoxic conditions. When a nascent cell is activated,
nearby cells within a ﬁxed distance (a zone of exclusion) are marked as complete.
This prevents overcrowding of the area due to too many cells moving towards the
source of VEGF. Programmatically, this is achieved by successively stepping away
from the activated cell until a threshold level is met, as opposed to a straight
vector length calculation which has the possible complication of aﬀecting cells on
the opposite side of the parent vessel. This distance can be modiﬁed in order to
increase or decrease the density of vessels grown, representing a pathological factor
in some diseases, such as Alzheimer’s (ﬁgure 4.6).
Cell movement is only allowed when the cell has reached the threshold time for
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cell doubling to occur, to represent the need to ﬁll in the space behind the moving
cell. On a cellular level, capillaries are formed from single cells forming tubular
sections, chained together to form vessels, and this constraint is designed to reﬂect
that.
Figure 4.6: Decreasing the size of the exclusion zone around an activated endothe-
lial cell results in increasing numbers of sprouting tip cells (top), and thus increased
vessel density (bottom).
As the density of growth factor increases, so does the possibility of branching,
that is, splitting into two vessels. Branching is a vital element in the formation of
vascular networks, as it allows for the space between larger vessels to be eﬀectively
ﬁlled. In order for a vessel to branch it must be of a threshold age. When branching
occurs, the original vessel sprout is considered to be complete and two new sprouts
produced, thus the age is reset. The net result of this is that one new agent
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is created and added to the environment at the location of the sprouting; this
location is randomized in the locale of the original endothelial cell, and follows
the constraint of occurring perpendicular to the direction in which the original cell
last moved (cell choice is eﬀectively determined by the dot product once again).
While random, the location of the new sprout is weighted by the density of growth
factors around the location of the old tip cell, so as to reﬂect the dependence of
growth on the chemical factor. The vector representing the diﬀerence between the
new cell and the original tip cell, that is the direction in which the the new cell
has sprouted, is assigned to the cell as the direction of last movement, and thus
encourages the sprout, initially at least, to move away from the parent vessel.
Anastomosis is an event which occurs when a migrating endothelial tip cell
comes into contact with another sprout. When contact occurs, the migrating tip
cell is essentially removed from the agent simulation, and the sprout becomes ﬁxed.
However, if an EC comes into contact with its own vessel sprout, anastomosis is
ignored; this is primarily to prevent terminal anastomosis, that is early termination
of the simulation due to random motion causing an EC to loop onto itself and
stop movement. This does not remove the possibility of a new sprout, as described
above, moving into its parent sprout and anastomizing. However, due to the uptake
of growth factor by occupied spaces and the diﬀusion element, this is unlikely to
occur; growth factor concentrations will be lower around vessels..
4.3 Physical constraints and boundary conditions
Every model is limited by the size of the simulation, although constraints vary over
diﬀerent models. Models of angiogenesis tend to be limited to a square or cuboid
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environment, with no-ﬂux boundary conditions imposed, such as in the model
developed by Anderson et al [3]. Some notable exapmles are that of Lemon et al
[48], who modeled angiogenesis within a virtual pore (analogous to an hourglass
shape) to simulate angiogenesis within a porous tissue engineering scaﬀold and
Perfahl et al [29], who employed diﬀering sets of boundary conditions: initially
no-ﬂux as employed by Anderson et al [3] but also periodic boundary conditions.
In this model, boundary conditions were set to be no-ﬂux, that is, nothing
can enter or escape the conﬁnes of the simulated volume; ﬂuids or agents. This
has the eﬀect of simplifying the model to some extent, removing the possibility of
external inﬂuences. A constrained volume is required to prevent the simulation
growing uncontrollably and arbitrarily increasing memory and processor require-
ments. Similarly, the size of the simulation is limited to an area approximately
1-2mm3, which maintains reasonable memory requirements and execution speed.
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Figure 4.7: A snapshot of a 1923 simulation running shows how complex the
network generated can become. Original scan data (bright red) can be seen through
the newly grown vessels (dark red) with moving tips cells higlighted in blue, and
newly generated tip cells shown in white.
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Chapter 5
Fluid dynamics simulation
5.1 Growth factor diffusion
A key element in the simulation is the chemical factors which trigger angiogenesis
[11]. When released by the body chemical factors such as Vascular Endothe-
lial Growth Factor (VEGF), Fibroblast Growth Factor (FGF), Platelet-derived
Growth Factor (PDGF) and others, trigger the growth of the particular cells
to which they are targeted. Of notable importance in angiogenesis is the fac-
tor VEGF, ﬁrst isolated in the 1970s from tumor mass, which until recently was
the only factor proven to be critical to the formation of blood vessels [49], and it
is this factor which is considered here. It is its profound eﬀect in the progression
of cancerous tumors that has lead to such interest in terms of research, and this
is why it is still the main focus of angiogenic studies.
Such factors are released by tumors into the surrounding tissue, through which
transport is mediated by diﬀusion. These chemical factors are subject to both
diﬀusion and decay, and thus must be produced in large enough quantities to
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create a sustained gradient in order to cause endothelial cell migration.
The most basic numerical ﬂuid dynamics implementation involves the diﬀusion
or heat equation, where ρ is the quantity of some substance and d is the diffusion
coefficient controlling the rate of ﬂow:
∂ρ
∂t
= d
∂2ρ
∂x2
(5.1)
In order to account for diﬀerent rates of diﬀusion through varying materials we
must solve the inhomogenous diﬀusion equation, which can be stated as follows:
∂ρ
∂t
=
∂
∂x
(
dx
∂ρ
∂x
)
(5.2)
In a discrete model, this can approximated using the ﬁnite diﬀerence method
as described in [47], which lends itself to a GPU-based implementation since it
involves iteration of every element of an entire grid. Using the backward Euler
formulation:
ρ(t+∆t)−∆t
∂ρ(t+∆t)
∂t
= ρ(t) (5.3)
We can rephrase (5.3), where ρ(t+∆t) is unknown, in matrix terms as:
Ax = b (5.4)
Where: b represents the vector of known initial values of ρ(t) in the system;
A represents the matrix formulation of the transform; and x represents the vector
of ρ(t+∆t) values we are trying to ﬁnd. We could compute the inverse of A and
multiply both sides to ﬁnd x, but for a sparse matrix such as a diﬀusion transform
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this is excessive. Instead we can use iterative relaxation methods that converge on
the solution to the linear system.
Let ρi = ρi(t), and ρ
∗
i = ρi(t+∆t), the discretization of 5.3 for the inhomoge-
nous diﬀusion equation in 1D then yields:
ρ∗i −
∆t
∆x2
(di+1 ρ
∗
i+1 − (di+1 + di−1) ρ
∗
i + di−1 ρ
∗
i−1) = ρi (5.5)
From this we can derive the base update equation for use in a relaxation
method:
ρ∗i (1 +
∆t
∆x2
(di+1 + di−1)) = ρi +
∆t
∆x2
(di+1 ρ
∗
i+1 + di−1 ρ
∗
i−1)
ρ∗i =
ρi +
∆t
∆x2
(di+1 ρ
∗
i+1 + di−1 ρ
∗
i−1)
1 + ∆t
∆x2
(di+1 + di−1)
ρ∗i =
∆x2 ρi +∆t (di+1 ρ
∗
i+1 + di−1 ρ
∗
i−1)
∆x2 −∆t (di+1 + di−1)
(5.6)
Setting an initial guess for ρ∗ (for example, ρ∗ = 0) and applying 5.6 over
several iterations causes ρ∗ to relax over time, converging on a stable solution
(though not necessarily an accurate solution). For the Jacobi method we would
replace ρ∗ on the left hand side with ρ(n+1) and the right hand side with ρ(n),
where n is the iteration number. That is, we would store the values of ρ(n+1)
separately from ρ(n) ready to use on the next iteration. It turns out that this is
not necessary, and in fact faster convergence is achieved when the results of the
current iteration are used immediately for computing the next grid vale along in
the lattice. This inline approach ﬁnally gives us the Gauss-Seidel method. In 3D
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the iterative update equation becomes:
a = ∆t (di+1,j,k ρ
∗
i+1,j,k + di−1,j,k ρ
∗
i−1,j,k + di,j+1,k ρ
∗
i,j+1,k
+ di,j−1,k ρ
∗
i,j−1,k + di,j,k+1 ρ
∗
i,j,k+1 + di,j,k−1 ρ
∗
i,j,k−1)
b = ∆t (di+1,j,k + di−1,j,k + di,j+1,k + di,j−1,k + di,j,k+1 + di,j,k−1)
Then:
ρ∗i,j,k =
∆x2 ρi,j,k + a
∆x2 + b
(5.7)
Where: ρi,j,k is the known value ρi,j,k(t); ρ
∗
i,j,k is the iteratively computed solu-
tion to ρi,j,k(t+∆t); and di,j,k is the location-dependent diﬀusion coeﬃcient.
5.2 Flow and pressure
The pressure model is constructed using the graph representation of the angiogen-
esis model described in chapter 4. Nodes are formed where sections of vaculature
meet, either through sprouting or anastamosis, which are connected by vessels
represented as pipes. In order to measure pressure across the graph, we must
calculate pressure values at each of the nodes. This is done by constructing an
electrical analogue model such that conductance (i.e. the inverse of the resistance)
of pipes is calculated, and pressure measured using a recursive algorithm.
The conductance, G, of a pipe is deﬁned as:
G = α
ρA2
8piµl
(5.8)
where A is the cross-sectional area of the pipe, l the length of the pipe, rho the
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blood density, µ the dynamic viscocity. Where α = 1, this refers to ﬂow across a
perfect cylinder; this value was used to provide a simpliﬁcation to the model.
The ﬂow rate, F , of a pipe can be deﬁned as the product of the conductance
of the pipe and the pressure diﬀerence, ∆p, across the pipe
F = G∆p (5.9)
This is combined with the continuity equation which states that net mass ﬂow
through any node which is not an in- or out-ﬂow node is zero, giving rise to the
equation for each node i, where Gij is the conductance of the pipe connecting node
i with node j :
n∑
j
Gij(pi − pj) = qi (5.10)
where qi deﬁnes the sum of in- and out-ﬂow rates from the node i.
By applying equation 5.10 to each node, a matrix of values can be constructed
which describes the relationship between the pressure values at each node as a
system of simultaneous equations, such that the following relationship holds:
Mp = q (5.11)
where M is the matrix of values constructed above, p is the vector of pressure
values at each node, and q is the vector of ﬂow rates at each node.
Flow rates are set to be constant values: 0 for the majority of nodes, 1 for an
in-ﬂow node and -1 for an out-ﬂow node, although these values can be changed
to reﬂect diﬀerent ﬂow characteristics of diﬀerent systems. The aim is to balance
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in- and out-ﬂow of the system. In- and out-ﬂow nodes are characterized as those
derived from the original geometry which reside on the edges of the domain. By
denoting the largest edge-residing section in vascular tree as an in-ﬂow node, the
remainder can naively be denoted as out-ﬂow nodes, following which a balanced
ﬂow proﬁle can be derived.
This equation is then solved iteratively for p until a steady state is reached.
The matrix of coeﬃcients, M, is diagonally dominant and, due to the nature of
the application, incredibly sparse for even high complexity graphs. Thus, it is
compressed before being transferred to video memory by storing only the non-zero
values and the respective row and column indices. Since nodes tend to have an
average of four pipes emerging from them, in a graph with several hundred nodes
the storage required is several orders of magnitude lower. Not only does this save
upload bandwidth and reduce memory requirements, but it also increases compu-
tational eﬃciency since only non-zero elements are required for computations. The
equation (5.11) is solved iteratively for p using the Gauss-Seidel method, however
other methods could be employed for larger systems such that greater eﬃciency
is achieved such as described in [50]. Iteration ceases once the system reaches a
steady state.
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Chapter 6
Implementing complex computation
on the GPU
Graphics processing unit (GPU) devices devote more of their hardware to raw
data processing, rather than reserving a large amount of architecture for memory
caching and ﬂow control, as with conventional CPUs. It is because of this that they
are best suited to data-parallel applications - linear arrays of data with each data
element processed via the same program - focusing on high arithmetic intensity
rather than memory operations. As a result, it is not a general purpose solution
to computational problems. In this work, NVIDIA’s CUDA (Compute Uniﬁed
Device Architecture) is used. This section will discuss implementation details
of both ﬂuid dynamics systems, and how the GPU increases performance. The
decision was made that the diﬀusion and pressure systems would be solved on the
GPU in order to exploit the massively parallel nature of the hardware for increased
performance.
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6.1 The parallel programming model
Programming in parallel requires an entirely diﬀerent way of constructing a pro-
gram to that employed when working with a linear processor like the CPU. The
GPU is speciﬁcally designed to run smaller, computationally intense programmes
multiple times in parallel, as opposed to a longer set of instructions which would
run in series. Even a low-end GPU (by current standards) can have as many as 384
cores, with those on high-end processors numbering in the thousands [51]. Further
to this is the design of the processor; graphics processors are speciﬁcally designed
to run multiple threads, with a single core on an NVidia processor being capable
of running up to 1024 simultaneous threads.
CUDA C is an extended version of the C programming language, which allows
for the creation of kernels which are functions that, when called, are run on mul-
tiple threads simultaneously. For example, a simple programme to add vectors is
given as follows:
Listing 6.1: A simple programme written in CUDA C.
__global__ void VectorAdd(float *A, float *B, float *C)
{
int i = threadIdx.x;
C[i] = A[i] + B[i];
}
int main()
{
// kernel invocation with N threads
VectorAdd <<<N, 1>>>(A, B, C);
}
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The above code adds two vectors A and B of length N and stores the result in
a third vector C. Then the programme is run, it creates as many threads (N) as
there are elements in the vector. Each of the N threads adds one component of
each vector, and hence the full vector addition is calculated. Note how the index
into the vectors (which are in this case stored as arrays) is deﬁned as the ID of the
thread, which is accessed through the built-in threadIdx variable. This variable
is itself actually a three dimensional vector; this assists in creating programmes
which run on blocks of data in two or three dimensions as well as one. Execution
is performed with the unique «<...»> syntax, which is an extension allowing the
deﬁnition of multi-dimensional arrays of threads. This example executes one block
of N threads.
Blocks are used to group threads together with the constraint that all threads
within a block must be executed on the same core. Since a single core can execute
up to 1024 threads, this constraint is passed on to the size of a block. Thread block
dimensions are deﬁned by passing a vector of sizes when executing a kernel, such
that the product of the sizes does not exceed the maximum limit for threads per
block. A thread block can be deﬁned as a one, two or three dimensional vector,
which allows for identiﬁers to be accessed as described above.
CUDA C is not an object-oriented language, and as such any operations are
performed on shared memory assets, stored in graphics memory. With a multi-
dimensional block of threads, the thread identiﬁer can be used as an index into an
array of the same dimension, giving a natural way to access memory from within
the kernel. Such a model of computation is ideal for modelling block calculations
as opposed to more intricate systems which require a single element to retain
information about itself.
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Figure 6.1: Threadblocks are representative of sub-slices of the overall simulation
volume, which are layered to form a grid for the purposes of execution on the
graphics card. Grids with diﬀerent coordinates are successively solved in order to
process the entire volume.
6.2 Diffusion
6.2.1 Diffusion equation
The transfer of chemicals within the tissue of the body is primarily though the
means of diﬀusion. For example, oxygen diﬀuses from the blood in the vessels,
through the endothelium, and into the surrounding tissue, up to a distance of
around 200µm (referred to as the diﬀusion limit of oxygen). The purpose of adding
a diﬀusion component to this system is to describe the motion of vascular endothe-
lial growth factor from a source, typically a tumor, in the tissue.
Diﬀusion is the spread of a ﬂuid through a space in a (usually) uniform manner,
as described by the diﬀusion equation:
∂φ(r, t)
∂t
= ∇ · [d(φ, r)∇φ(r, t)] (6.1)
which describes the rate of change of density (φ(r, t)) at time t at location r
with respect to time, d(φ, r) is the diﬀusion coeﬃcient at r, and ∇ is the vector
diﬀerential operator del.
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The diﬀusion problem consists of needing to know the ﬂuid density at a spe-
ciﬁc location within the simulation environment. Thus, the diﬀusion equation is
solved for each location within the three-dimensional grid simultaneously using
the forward diﬀerence scheme described in chapter 5, and a Gauss-Seidel method
of computation.
6.2.2 Memory requirements
When setting up the diﬀusion solver, certain memory requirements have to be met.
Initially, a three-dimensional array of ﬂuid concentration values is required which
represents the current state of the system. The dimensions of this array must match
the dimensions of the simulation environment. Using a three-dimensional array
instead of an appropriately sized one-dimensional array allow for threads running
the diﬀusion kernel to index into the array using the thread identiﬁer “threadIdx” as
described in the previous section, along with the block identity “blockIdx”. Block
identities can be indexed in much the same way as thread identities, and when
used with an invariant block size can simply be multiplied up to retrieve the full
index into the array.
As a single thread block can support up to 1024 unique threads, a reasonable
size for the block is eight in each dimension, giving a total of 512 threads. While
this may seem like a waste of computing resources, it ﬁts nicely with the convention
of using powers of 2 in computer science. Thus, simulation environments can be set
up with sizes which are multiples of 8, allowing for easy splitting of the environment
into blocks. This also aligns well with memory, preventing the need for padding
bytes.
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To implement the Gauss-Seidel algorithm the system is double-buﬀered. The
programme is able to overwrite the current value of guess with the newest guess, in
line with the operation of the Gauss-Seidel method. In order to safeguard against
incorrect values being read from memory, all read and write operations must be
atomic in nature, that is the operation is guaranteed not to be interrupted by
another thread, and the CUDA API provides this capability through a set of
dedicated functions. Thus the above memory requirement is doubled.
Further to this, diﬀusion constants are required for the entire simulation envi-
ronment, but since these do not change during execution of the diﬀusion solver,
only a single array is required. As before, a three-dimensional array is used to
allow for a natural method of indexing based on thread and block identities.
These arrays are stored in memory on the graphics card, typically referred to as
the device, however there is also the need for an array of ﬂuid density values within
main, or host, memory, such that access to values by cells is as fast as possible.
This array will be equal in size to its counterpart on the device. Transferring data
between device and host memory is a bottleneck, however the increases gained
through the accelerated computation speed of the GPU, and local memory access
speeds for cells (as opposed to numerous individual reads from GPU memory)
more than make up for this.
6.3 Pressure
Being its primary function, the movement of blood is of key interest in studies
of vascular structure and function. At its most basic level, the vasculature can
be described as a series of tubes. These tubes vary in length, and diameter, and
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in function. An appropriate analogy might be to compare the vascular network
to a tree; larger vessels are more akin to the trunk, which supports the smaller
branches through the transfer of water (analogous here to blood), however it is
not until the smaller branches where the water is transferred to the leaves (akin
to our tissue). It is at the microvessel level where the walls become thin enough
to allow the passing of nutrients and waste products to and from the blood.
Poisueille’s 1840 work “Recherches expérimentales sur le movement des liquides
dans les tubes de très-petits diamètres” on the movement of ﬂuid in pipes led to
Poiseuille declaring the relationship between the ﬂow rate (Q) of liquid through a
pipe of uniform diameter(D) and ﬁxed length (L), and the diﬀerence in pressure
across the length of the pipe (p), as follows:
Q = k(D4p/L) (6.2)
where k is a constant. This can be rearranged to give what is commonly referred
to as Poiseuille’s Law, deﬁned as:
∆P =
8µLQ
pir4
(6.3)
where ∆P is the pressure diﬀerence across the pipe, L is the length, Q is the
volumetric ﬂow rate, µ is the dynamic viscosity of the ﬂuid, and r the radius of
the pipe, pi being the mathematical constant pi.
With respect to the dynamic viscosity of the blood, the work of Pries et al.[41]
comes into play, with their equation for “relative apparent viscosity”, which de-
scribes the phenomenon of a sharp increase of apparent viscosity observed in vivo
for vessels of diameter smaller than (approximately) 20µm (see diagram 6.2), and
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Figure 6.2: Relative apparent viscosity, as described by Pries et al., shows a sharp
increase in the apparent viscosity of blood at very small vessel diameters. This
is due to the nature of blood as a ﬂuid being not uniform, but a suspension of
particles (red blood cells, primarily) in a ﬂuid (plasma).
is of the form
ηvivo = 1 + (η0.45 − 1) ·
(1−HD)
C − 1
(1− 0.45)C − 1
(6.4)
where HD is the discharge haematocrit for vessel diameter D ; η0.45, the relative
apparent blood viscosity for a ﬁxed discharge haematocrit of 0.45, is given as
η0.45 = 220 · e
−1.3D + 3.2− 2.44 · e−0.06D
0.645
(6.5)
and C describes the velocity dependence on haematocrit as
C = (0.8 + e−0.075D) · (−1 +
1
1 + 10−11 ·D12
) (6.6)
In the range of vessels of 7µm to 100µm, the diﬀerence in apparent viscosity
of blood with discharge haematocrit 0.45 and cell-free plasma (haematocrit 0) is
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Figure 6.3: Flow is preserved across a node. The sum of the ﬂow into the node
(Q0) is equal to the sum of the ﬂow out of the node (Q1 + Q2)
only 25%, indicating a weak dependence on haematocrit [52]. As such, a compu-
tational simpliﬁcation can be made of assuming a discharge haematocrit of 0.45,
rendering the fractional term of equation 6.4 equal to one, leaving the viscosity to
be described by the ﬁxed term of η0.45, equation 6.5.
If we consider once again the vascular network, and how we see it is described
by a series of tubes, we begin to form a concept of how blood ﬂow can be described
using equation 6.3. Consider ﬁgure 6.3, which displays a simple bifurcation in a
vessel. This can be considered as three pipes, having ﬂow rates of Q0, Q1 and Q2.
The graph topology is derived from a simpliﬁcation of the vascular network
created using the algorithm described previously. Figure 6.4 shows a side by
side comparison of a simple vascular network produced by the vascular growth
algorithm, and a visualisation of the corresponding graph representation used in
the pressure calculations. Sections of microvasculature generated are treated as
straight pipes in order to reduce the complexity of the calculation. Here, a section
is any uninterrupted length of vasculature in the resulting network; where a vessel
branches, or is met by another sprout, a node is formed.
Calculating blood ﬂow is performed by solving for pressure on the GPU, which
becomes a case of formulating the network as a large system of simultaneous equa-
tions. The problem, then, is solving a system of equations with many hundreds of
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variables, and thus an iterative system such as Gauss-Seidel once again becomes
attractive as it allows solution of each equation in a semi-independent manner.
Equations are created for the pressure at each node, that is any location where
two or more pipes or sections of pipe meet. The pressure at a given node is given
by equation 5.10. As such, we construct equations relating the pressure values at
each node to ﬂow rates at the in- and out-ﬂow nodes. In this context, an equation
is a list of coeﬃcients of conductance values of pipes which meet at the speciﬁed
node, multiplied by the pressures, such that a large, sparse, diagonally dominant
matrix A is formed which satisﬁes the condition:
Ax = b (6.7)
where x is the vector of node pressures, and b the vector of ﬂow values. It is
important to note at this point that the ﬂow values are ﬁxed, and for the majority
are zero as they refer to the sum of in- and out-ﬂows at a particular node. In-ﬂow
nodes are designated a positive ﬂow value, whereas out-ﬂow nodes are designated
a negative ﬂow value.
In a complex system, a square matrix of many hundreds of lines can be pro-
duced. However, due to the nature of the system, a large majority of elements in
the matrix are zero, and thus require no storage. In fact, when we consider that an
equation is required per-node, it becomes clear that the storage requirements for
the matrix can be reduced to the use of row and column indices and element values
for non-zero elements only. The choice to treat uninterrupted sections of generated
vasculature as single straight pipes further reduces the size of the matrix.
Programming the iterative scheme for the GPU requires choosing an algorithm
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Figure 6.4: A side by side comparison of a simple vessel network grown with
the algorithm described previously and the graph representation for the pressure
calculations. The graph assumes straight pipes for conductance calculations but
uses vessel length instead of the straight line distance between nodes.
which can operate on each equation, that is each line of the matrix, independently,
in order to solve the equation Ax = b. Initially, a simple scheme such as Jacobi
seems attractive as it works on each line, iterating once each new x (pressure)
value has been computed. However, other schemes could be implemented, such as
those in [50].
This line-based method for solving the equation, along with the storage re-
quirements outlined above, deﬁne the method for storing the main matrix M in
memory. This is comprised of three arrays for storage of values as follows:
• an array, Av, of all non-zero values in the matrix, packed in sequence from
left to right, top to bottom.
• an array, Ac, of column indices for each element in the array Av - each
column index Ac[i] relates the element of the matrix M [i]
• an array, Ar, of row indices, where each element Ar[i] contains the index in
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Av of the ﬁrst element in the row i.
With this are two more arrays, one for the x vector and one for the b vector.
Additionally, an array of convergence ﬂags can be implemented to allow early
termination of the algorithm.
Since these arrays are only populated at the beginning of the solving sequence,
elements can be read from them with the conﬁdence that they have not been
modiﬁed by the solving function (kernel).
Figure 6.5: Example graph: ﬂow values at nodes p1 and p3 are ﬁxed as 1 and
-1 respectively, and given ﬁxed pressure values. Conductances g1, g2 and g3 are
calculated for each section of vasculature.


g12 −g12 0 0
−g12 g12 + g23 + g24 −g23 −g24
0 −g23 g23 0
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
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
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(6.8)
The equations are solved iteratively for p using the Gauss-Seidel method, how-
ever other methods could be employed for larger systems so that greater eﬃciency
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Figure 6.6: Pressure is stabilised across the network after successive iterations of
the algorithm. Pressure values range from 75mmHg to 55mmHg, as deﬁned as the
in- and out-ﬂow pressure values, which are ﬁxed.
is achieved, such as those described in [50]. Iteration ceases once the system reaches
a steady state.
6.4 Mass transfer
The main function of blood within the body can be characterised as the transfer
of materials from one location to another. Blood carries nutrients, such as oxy-
gen, throughout the vascular network, as well as antibodies and waste products.
However, this same transport mechanism can transfer harmful substances, such
as bacteria, or therapeutic substances, such as drugs, as well. Thus, modelling
the transfer of materials through the vascular system has wide-reaching implica-
tions in terms of planning treatment regimes or assessing the possible eﬃcacy of
therapeutic treatments such as chemotherapy [53].
Mass transfer in vascular networks is controlled by two processes; advection
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Figure 6.7: Modifying the graph by introducing low pressure nodes shows how the
algorithm stabilises under diﬀerent conditions.
and diﬀusion. Advection is the transfer of mass through bulk movement of the
surrounding material. Within the vascular system, advection occurs as blood
moves through the system, causing movement of a substance dissolved within the
blood ﬂuid. This is particularly important within the larger vessels as the blood
moves at a much faster rate than in microvasculature. Diﬀusion can occur in
the absence of bulk motion, and lacks a macroscopic explanation. Diﬀusion is
explained by motion on a molecular level, and is the result of the random motion
of particles at a microscopic scale.
6.4.1 Mass transfer by advection
When considering the eﬀects of advection on mass transfer within a system such
as human vasculature, it is important to consider what is happening. Advec-
tion within the vasculature is the result of the motion of blood, as propelled by
the pumping action of the heart. As described above, the simulation calculates
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pressure values for pipe intersections, thus the pressure diﬀerence across a pipe,
∆p becomes trivial to calculate. Using this pressure diﬀerence, we can apply the
formula for ﬂow rate of ﬂuid in a pipe
Q =
D4pi∆p
128µl
(6.9)
where Q is the ﬂow rate, D is the diameter of the pipe, µ is the speciﬁc viscosity
of the ﬂuid and l is the length of the pipe. Flow rate is calculated in cubic metres
per second, and thus by multiplying the ﬂow rate by the simulation time step, ∆t,
we can measure the volume of ﬂuid moving out of, or into, a pipe in this time.
We model the node volume as opposed to pipe volume. We deﬁne node volume
as follows
N =
1
2
k∑
i=0
Pi (6.10)
where Pi is the volume of pipe i which has one end at the node in question.
Thus the total volume of the system can be expressed as the sum of the node
volumes.
To model mass transfer by advection, we look at the transfer of liquid between
nodes. Recalling that the net ﬂow across a node is 0 (except in boundary cases)
and considering the ﬂow rates calculated as above, the movement of solutes is
modelled as a change in overall concentration at a node. This is discussed in more
detail in the following section, but is based on multiplying concentration fractions
at each node with the volume of ﬂuid moving through the pipe. The whole system
is double buﬀered to reﬂect the nature of the process taking place, i.e. all elements
being calculated simultaneously.
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Diﬀusion plays a role in the transfer of mass throughout the vasculature. In this
model, diﬀusion is limited. The concept of diﬀusion is used here when considering
the mass concentration within node volumes. Let us consider the result of a single
simulation step between two connected nodes; we deﬁne the higher pressure node,
nh, as having volume vh and solute concentration ch, and the lower pressure node
nl, as having volume vl and solute concentration cl. There is movement of a ﬁxed
volume ∆v of blood from the higher pressure node to the lower pressure node, as
well as the removal of the same volume of blood from the lower pressure node.
Since we assume node volume to be constant, this results in the low pressure node
having combination solute concentration of
(vl −∆v) · cl +∆v · ch
vl
(6.11)
It is at this point that we must consider the eﬀects of diﬀusion. The rep-
resentation of solute concentration as being calculated on a per-node basis is a
discretization of an inherently continuous property. It would be computationally
infeasible to expect to be able to represent a spectrum of such a property at a truly
accurate (i.e per-molecule) basis. Thus, the concentration values we calculate for
each node are in fact average concentrations, as we assume mixing due to diﬀusion
within a node. We consider this assumption reasonable due to the volume of the
pipes and the time scale (100ms per step) of the simulation.
There are some obvious computational simpliﬁcations in this scheme which
are ideal targets for improvement. Whereas pipes in this model are treated as
straight and rigid, the method of calculating conductance lends itself to modelling
more complex pipe geometry. Increasing the accuracy, and therefore complexity,
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of conductance calculations would obviously result in an increase in processing
requirements, although these values change infrequently and thus need not be
recalculated often.
While the model deals with mass transfer through the vascular network, it does
not incorporate any absorption terms. Absorption of solutes through the vessel
wall is moderated by a collection of factors, including the rate of diﬀusion per
unit area (itself dependent on the transport mechanism and vessel wall thickness),
the surface area of the vessel, and the volume of tissue behind the vessel wall.
This can be modelled using a scheme similar to the one proposed in [54], via the
application of Fick’s Law of diﬀusion. While the majority of this is reasonably
trivial, association of tissue volume to vessels requires some segmentation of the
simulated volume; this can be reasonably easy to achieve in simulations of a ﬁxed
network, but application to a growing network would be somewhat more complex.
Furthermore, it is important to remember that blood carries not one but a mul-
titude of solutes, through diﬀerent transport mechanisms. Oxygen, for instance,
is transported via the red blood cells (RBCs) themselves - thus oxygen transport
is dependent on the fraction of RBCs in the blood (haematocrit) ﬂowing through
the vessel in question. On top of this is the fact that the smallest vessels are at
times smaller than the width of a single RBC, which results in compression as
they move through. Other mechanisms of transport across the endothelium are
numerous, in particular across the blood-brain barrier [55], [56],[57], a functional
boundary between cerebral vasculature and the tissue of the brain itself.
The particular coupling of a model of angiogenesis and advection-based trans-
port lend themselves to simulation of blood-brain barrier interactions. Since we
deﬁne each unit length of vasculature generated as equivalent to a single endothelial
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cell [58], we can make assumptions about where the tight junctions (those where
the cell bonds to itself or other endothelial cells to create tubular structures) are,
i.e. between each unit of vasculature, and to a lesser extent along one edge of each
unit.
6.4.2 Delivery of mass to the body
The rate at which diﬀusion across the capillary endothelium occurs is dependent
on the location of the vessels in the body. The cerebral vasculature are tightly
regulated to protect the brain from transfer of toxic substances (although this is
not always eﬀective), whereas kidney and liver vessels are designed to allow for
eﬃcient cleaning of the blood as it travels through.
There are several cases we can consider when it comes to mass transfer in
therapeutic circumstances. These include the transfer of metabolites, such as
oxygen and glucose, the removal of waste products, and the targeted transfer of
drugs. The majority of these can be categorised as the diﬀusion of substances
across the endothelium into the surrounding tissue.
With respect to the grid-based network described in previous chapters, calcu-
lating the rate at which solutes are transferred across the endothelium requires
knowing the surface area of vessel over which the solutes are diﬀusing. This can
be achieved by counting the number of empty spaces adjacent to the vessel (see
ﬁgure 6.10).
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Figure 6.10: Counting spaces adjacent to a vessel segment - in this simpliﬁed (two-
dimensional) example, the location marked ’a’ has two adjacent spaces, whereas
the location marked ’b’ has only one.
A simple tubular section in the middle of a straight vessel will have four neigh-
bors. The surface area of this section can be calculated simply with
SurfaceArea = pir2l (6.12)
where r is the radius and l is the length of the section. Aligning this with
the grid-based representation here, it is easy to see that the surface area repre-
sented by a single neighbor is a quarter of this. This is appropriate for straight
sections, however for more complex sections computing the surface area becomes
more diﬃcult. A few strategies are available for this problem.
The most naïve and computationally intensive solution is to calculate the sur-
face area of each section for each simulation step. While accurate, this has obvious
disadvantages. A more eﬃcient scheme involves a simpliﬁcation to the surface area
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calculation. Based on the above measure of surface area between neighboring lo-
cations, the surface area of any section can be approximated as:
SurfaceArea = n
pir2l
4
(6.13)
where n is the number of neighboring locations which are empty.
A ﬁnal solution is to create a lookup table based on the possible conﬁgurations
of pipe intersections. By limiting the calculations to the six nearest neighbors (± 1
unit in the x, y, or z dimension), this reduces the complexity of such a scheme to a
maximum of 26 possible combinations. This can be further reduced by considering
that many combinations are rotations of others.
6.5 Programming for the GPU
Given the update equation 5.7 deﬁned in chapter 5, and the memory require-
ments outlined above, writing the kernel for the diﬀusion programme is reason-
ably straight forward. Computing the next iteration involves retrieving both the
diﬀusion constants and the ﬂuid densities at the location to be calculated and
its neighbors in each dimension. These are accessed using the thread identiﬁer,
threadIdx, as follows:
fluidVal = fluidArray[threadIdx.x][ threadIdx.y][ threadIdx.z];
here, the current value of the location is retrieved. To access the neighboring
values, the array indices are modiﬁed.
Once the diﬀusion constants and ﬂuid values have been retrieved, these are
used to calculate the varying components of equation 5.7, with a time step (∆t)
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value which is chosen at the beginning of execution, and a constant grid spacing
(∆x). The result is then written back into the ﬂuid array, to be used to continue
execution.
Calculating the pressure values revolves around a similar set of operations,
including the execution of the kernel (although here we execute a linear array
of threads, one per line, as opposed to a three-dimensional grid), and memory
fetching operations.
Using the Jacobi iterative formula:
xk+1i =
1
aii
(bi −
∑
j 6=i
aijx
k
j ) (6.14)
we can compute iterative values of x, which represent the pressure values.
When calculating by hand, the above formula is used on each line of equation
6.7, however the GPU kernel allows for simultaneous evaluation of each line on
a separate thread. The Jacobi method requires each line to be complete before
the next iteration is calculated, but due to the very sparse nature of the matrix
A, each iteration only involves a small number of items to be summed, and thus
diﬀerences in execution time between lines will be very low.
Integrating with the main programme requires developing a set of access and
control functions to initiate execution on the GPU and deal with memory allocation
and access. The CUDA API provides a library of functions which are available
to manage memory and programme execution on the graphics card. Rather than
using the new operator as is normal in C++, we must make use of the functions
cudaMalloc and cudaMalloc3D, which allow for the allocation of one-dimensional
and three-dimensional arrays respectively, as single blocks of memory, enabling us
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to access it in the manner described above.
Similarly, modifying or retrieving values in graphics memory from the CPU
involves using dedicated functions cudaMemset and cudaMemcpy respectively.
These functions are designed to work the same way as their C counterparts, mak-
ing memory manipulation easy for anyone with some level of C programming skill.
Use of these operations is minimised, however, since transfer between graphics
memory and main memory is slow.
6.6 Unifying a modular system
Until now, the various components of the system have been discussed as separate
systems, almost acting independently of one another. At this point it is important
to consider the functional unit of the simulation. As a discretised model of a
continuous system, the simulation environment is described as a three-dimensional
grid of adjacent locations, which reside within a cubic section of tissue. The term
functional unit refers to an abstract concept which does not represent any physical
part of the system, but instead describes any single location on the grid, and
encapsulates the properties of the cellular motion, diﬀusion, and pressure sub-
systems at that location.
The concept of this system abandons that of typical layered multiscale models,
which involve modelling on a variety of biological timescales [59], and instead
adopts a centralised model where each subsystem acquires information about the
others through this functional unit. This is achieved through the use of a messaging
system which has the eﬀect of decoupling sub-systems from each other and allowing
a modular approach to simulation building.
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The functional unit, being just a single element in the grid, is created for each
element in the grid. As such, a centralised controller is created which handles
their creation at run time. It is through the controller that a subsystem registers
which properties are available for the functional unit to retain, through a function
supplying a property name and type. This is done at the beginning of the simula-
tion, before the grid is created, so that each unit in the grid is initialised with the
same properties. Properties can be numerical values, such as chemical densities or
occupancy, or can be pointers to a larger structure elsewhere.
Each subsystem is responsible for updating the functional unit as required.
When a subsystem requests a value from the functional unit, the unit must return
whatever value it currently holds for the property requested.
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Figure 6.8: Mass is transferred throughout the network over time as advection
takes place. The density of the solute appears to reduce in the main vessel as it
spreads throughout the system.
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Figure 6.9: Example of growth of a capillary network over time. Initially, cells
are nascent. Introduction of a growth factor gradient (pink) activates cells (blue
cells) around which is an exclusion region (red cells). As the growth factor density
reaches a threshold level, activated cells migrate towards the source of the gradient.
New vessels are drawn diﬀerently to highlight topographical features.
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Chapter 7
Individualised modelling
7.1 Introduction
In 1895 Wilhelm Röntgen discovered X-Ray radiation, and noted how the human
body absorbed these rays in diﬀering amounts throughout the diﬀerent types of
tissue [60]. This, combined with photographic paper, gave way to the ﬁrst form
of what we recognise now as medical imaging - that is, advanced techniques which
can image the inside of the human body in a non-invasive way. In the last few
decades medical imaging has provided an increasingly accurate way of viewing the
internal state of a body (or other object, as these techniques are not limited to
living things) without the need for any invasive procedures, such as exploratory
surgery. The uses of imaging techniques are widespread, and partial or complete
body scans are common in diagnostic medicine; for example, ultrasound scans for
assessing the health of an unborn child.
The advent of new imaging techniques, and later more powerful scanners, has
oﬀered a way of viewing more than just two-dimensional images of the inside of the
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body, such as an X-Ray displays. Some modern scanners, such as MRI machines,
are capable of acquiring entire volumes of space as a series of 2D images, or slices,
which when composited form a three-dimensional image of the body being scanned.
Others rely on post-processing of a series of images, such as X-Ray Computed
Tomography, which takes X-Ray images acquired at speciﬁc intervals across a
180 degree rotation to reconstruct a three-dimensional image of the object being
scanned.
Thus, an accurate internal representation of the body can be obtained. It is
from this that we are lead to the idea of personalized medicine, that is the cus-
tomization of treatments to individuals based on the physical features of their
internals. Such an approach has been used already in surgical planning, for ex-
ample in measuring the width of an artery where a stent is required to provide a
personal, custom piece of equipment and personal treatment.
Beyond this, however, is the idea of predictive medicine - taking a persons
unique data and using that to provide a model of how a disease is likely to progress.
The idea that vascular structure is relevant in disease is becoming ever more preva-
lent in the research community. The need for modelling based on a persons own
unique data thus becomes more apparent.
7.2 Personalised medicine
More common these days is the idea of personalised medicine. This is the concept
of speciﬁcally tailoring treatments and diagnoses to an individual, based on not just
medical history, but actual data regarding the patients physical body. Scanners
are now a permanent ﬁxture in every hospital, and their use in diagnosing a variety
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of maladies is routine, such as the use of X-Ray imaging in the diagnosis of broken
bones and obstructions, to the use of Magnetic Resonance Imaging (MRI) in the
diagnosis of cancer.
In fact, MRI scans are now commonly in use during the planning stages of
cancer surgery and the design of replacement bones for those who require them.
The evolution of this is predictive medicine: personalised simulations of the pro-
gression of disease, in order to best plan treatment of a condition. As scanner
ﬁdelity increases, and our knowledge of disease pathogenesis grows, it becomes ap-
parent that the combination of these elements could lead to improved treatment
of medical conditions. This can also be applied to simulating the eﬀects of a given
treatment, to predict how a patient might respond over a given period of time.
7.3 Imaging
The type of images required is governed by the particular application required.
For example, design of an implant, and surgical planning for ﬁtting, can use data
retrieved from a full body MRI scan at resolutions oﬀered by typical strength
scanners found in many hospitals, since they oﬀer sub-centimetre, and even sub-
millimetre accuracy. However, modelling of phenomena such as cell growth requires
a much greater resolution, in the region of micrometres, to match that of the size
of the cells being modelled and accurately represent the surrounding environment.
The images used in this work were MicroCT scans. The reason for this is that
the scanning resolution is very high, up to values as small as 5µm [61]. This value
corresponds well with the size of endothelial cells, which are the main target of
the model.
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It is at this point that we must consider the structure of blood vessels, and
how this aﬀects and is aﬀected by the process of angiogenesis. Blood vessels,
particularly the microvasculature, are composed on the outer layer of a matrix
of endothelial cells. During the early events of angiogenesis, endothelial cells are
recruited from the vessel wall by the angiogenic factors, and start migrating up
the factor density gradient.
Thus, in terms of modelling this phenomenon, we must be able to model en-
dothelial cell movements on a scale at least equivalent to the size of a single cell
- that is, the domain in which we model is split into units of approximately one
endothelial cell in size. This leads to the assumption that each location in the grid
is either ’on’ or ’oﬀ’, that is occupied or empty. It allows for easier testing in terms
of whether a cell can move into a location in the simulation space, or not.
We can also consider the structure of capillaries at this stage. Because the
larger vessels are considerably wider, the circumference of such a vessel will be
composed of multiple endothelial cells. However, capillaries are not structured
this way. In fact, a capillary is similar in size to a single endothelial cell - its
circumference is created by a single cell forming a tubular section, which is then
connected to other sections to produce longer pipe structures.
The scan data is being used to create the initial conditions for the simulation.
The idea here is that the scan shows the existing vasculature, and the simulation
is run to discover how the introduction of angiogenic factors aﬀects it. So when
images are loaded in at the beginning of the simulation, some thresholding is per-
formed to determine which locations in the simulation space are already occupied.
Since the scan data relates to vascular structure, this is then taken to mean that
an occupied space relates to an endothelial cell in the vessel lumen.
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Following this, the diﬀusion coeﬃcients for the occupied locations are set to a
higher value, which represents the decrease in permeability compared to that of the
extra-cellular matrix. Vessels are then hollowed out. This is achieved by locating
occupied cells which have occupied neighbors in all six of the principle directions
(up, down, left, right, forward, backward) as described by ﬁgure 7.1. These are
removed from the simulation, since they represent areas within the vessel, which
would be ﬁlled with blood. These locations, which now appear empty, are marked
as ﬁlled, however, to prevent the accidental movement of a cell into the vessel
space. In vivo this would be prevented by the mechanics of blood ﬂow; pressure
of blood would push cells outward. Similarly, the migrating cells bind onto the
extra-cellular matrix, and this would be absent, and thus there would be nothing
onto which the cells could anchor themselves.
To construct the initial graph representation of the vessels for blood ﬂow sim-
ulations slices are processed as they are imported into the simulation. For each
slices, regions are calculated using region growth, and individual regions are tagged
as sections of pipe in the graph. These are approximated as having a length equal
to the thickness of the slice (deﬁned by the scan resolution), and are idealised
slightly by calculating a radius based on the area of the region; assuming a circu-
lar section, this is easily calculated as r = 2
√
pi
A
.
Pipe sections generated in this manner are connected through detection of
overlap in successive slices, and graph nodes are created in-between these sections.
In the event that a new region overlaps more than one region in the previous slice,
this is easily handled by the graph system.
At the same time, the endothelial cells instantiated by processing the slices
are assigned to the pipe sections created from the same region. This ensures that
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(a) An example of scanned images before hollowing is performed, sections are described
as contiguous solid blocks. A white pixel denotes space taken by the resin cast, whereas
a black pixel denotes an empty space.
(b) The green pixel is identified as having six neighbors, and thus is marked for deletion.
(c) The result after hollowing is complete. Note that pixels on the edge of the domain
are assumed to have a neighbor outside the domain which prevents formation of “caps”
on the ends.
Figure 7.1: The hollowing process removes internal pixels to provide a more natural
seeding process for endothelial cells.
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when they begin to move, the pipes they generate are correctly connected to the
original graph.
7.4 Limitations of image based methods
It is incorrect to assume that the structure of vasculature is so regular; in vivo the
cells which form the vessel walls are not axially aligned, nor entirely uniform in
size. These assumptions, however, make the model vastly simpler to create and
interpret. A future improvement would be to work on a much smaller grid, perhaps
10 times higher resolution, such that an endothelial cell takes up a larger space in
terms of grid locations, but can move in a smoother way, or perhaps to take it a
step further through the use of a continuous space for such movement. Currently,
the model works on the Anderson and Chaplain method of checking a probability
of movement based on how much VEGF has been absorbed, along with the local
gradient of growth factor, and the contents of surrounding grid locations.
The images used in this research were MicroCT scanned images of resin cast
rat cerebral vasculature. The resin cast is created by injecting liquid resin into the
blood vessels of terminally anaesthetised rats, which is then allowed to set. Once
the resin has set, the remainder of the tissue is dissolved with acid to expose the
cast.
This allows the inspection of the vascular structures without the surrounding
tissue, which means that scans become much more binary in nature - either a
location is ﬁlled with a section of vasculature, or nothing at all. This, of course,
ﬁts in nicely with the prescribed initial conditions of the simulation, such that
either a location is populated by an endothelial cell, or it is empty.
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The resin casts were scanned in a SkyScan1174 compact microCT X-Ray scan-
ner in which rotational X-Ray images are taken at an interval of 0.5 degrees. These
images are then reconstructed using an implementation of the Feldkamp algorithm
[61] which results in a new set of images corresponding to horizontal slices. These
slices, when laid on top of one another in order, represent the entire volume in
three-dimensional space.
Of course, we cannot use this method to acquire images of living patients.
Typically, internal images of humans are taken using MRI scanners. In contrast
to a MicroCT scanner, which typically has a functional resolution in the range of
microns, the resolution of an MRI scanner is usually in the range of millimetres.
This scan resolution is eﬀectively limited by the strength of the magnetic ﬁeld
generated by the scanner.
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Chapter 8
Modular Analysis on the Cloud
8.1 3DNet
The 3DNet Medical cloud system was developed by Biotronics3D and was de-
signed around the idea of moving the functionality of a medical imaging software
package to a cloud-based system, removing the need for users to acquire dedicated
hardware. Medical imaging requires a considerable amount of power, and as such
makes an ideal candidate for cloud computing. Typically, medical imaging solu-
tions are high-end applications which require expensive hardware, and at times
similarly expensive software. Thus, removing the hardware component by moving
the functionality from local machines and into a cloud solution is an appealing
prospect as it will greatly reduce the cost.
As a way of ensuring the relevance of the 3DNet Medical cloud system, it has
to be capable of expanding with new technologies and techniques. To this end, a
modular system for integrating new functions was devised. Modular frameworks
have been in use for some time, often termed plugin systems, and can be seen in
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a number of computer applications.
The cloud system described in chapter 3 forms the basis on top of which the
module integration framework was built. The framework is composed of three
separate components which communicate to each other using messages passed via
web service and DICOM association. The following sections provide an overview
of the interactions between components, followed by detailed descriptions each
component.
8.2 A flexible pipeline for medical image analysis
We developed a ﬂexible pipeline for integrating analysis modules into the 3DNet
Medical system in the early stages of the project. This pipeline allows for the
generation of rule sets to identify incoming scans which ﬁt the criteria for a par-
ticular module, and can be automatically submitted to the analysis subsystem for
processing. Studies can also be manually passed to the analysis subsystem at any
given time, through a UI option integrated into the main system. The framework
design is speciﬁcally tailored towards easy integration of a wide range of code mod-
ules, essentially anything which can be compiled to an executable or can exist as
a standalone DICOM node. The importance of such a scheme is that it makes
creation of novel analysis modules more attractive to developers who would not
normally have the resources to develop an entire medical imaging solution.
In the 3DNet Medical cloud, the analysis subsystem is run on a separate server,
which ensures a dedicated set of resources for analysis tasks. The overall system
is divided into four separate components, which act on the data in turn. Each
module is conﬁgured by the addition of an XML ﬁle describing the module, in
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a speciﬁc directory the analysis server scans periodically for changes. Any new
ﬁles are parsed by the server, and the details added to an internal list of available
modules.
Data is passed to the analysis server and back via an exploitation of the DICOM
standard which allows the inclusion of metadata in unique tags. DICOM compliant
applications are allowed to only add private tags, and as such the server must
scan incoming ﬁles for the relevant tags, identiﬁed by a unique string as per the
requirements of the DICOM standard. A tag block then contains information
regarding the size and type of the ﬁle being transferred. The ﬁle itself is embedded
in the end of the DICOM carrier ﬁle, in the pixel data element - it is important
to note that the pixel data has no requirement to be only the size speciﬁed by the
DICOM header, and thus extra information can be safely added to the end of the
ﬁle.
In the current form, the Analytic Module Manager (AMM) queues incoming
studies for analysis, using a ﬁrst-in-ﬁrst-out scheme, and releases them to the
individual analysis modules one by one (ﬁgure 8.3). Under this scheme, each
module can be executing only once, initially, although multiple diﬀerent analysis
modules can be executing simultaneously. However, this can be scaled up to
allow for multiple instances of a single analysis module to be executing in tandem.
Return values from complete analysis modules are caught by the AMM. Depending
on the return value received, the AMM can choose to run a module again, if there
were problems, discard data after a given number of failed attempts, or return
successful results to the main system for storage.
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8.2.1 Event-driven workflow
Liu et al [62] put forward a framework for an event-driven workﬂow management
system, which included elements of both automatic and user-interactive image pro-
cessing [62]. Their system includes management of the image database including
standard image viewing and editing capabilities, and thus was somewhat beyond
the scope of this project. An event-driven system is a system of components which
interact with each other using messages. This method of interaction through mes-
sage passing is key in the design of such a system, in that it means that any
component can run independently, without the need for the other components to
be available. It implies a robust structure which allows elements to continue to
function in the event of a partial system failure, a desirable aspect in a system
distributed across multiple machines or sites.
The module integration framework was split into three distinct elements: the
Module Wrapper, which initiates execution of the module (Section 8.2.4), the
Analytic Module Manager, which controls data transfer between modules and the
main system (Section 8.2.3), and the Logic Engine, which deﬁnes when to execute
a module (Section 8.2.2). The ﬂow of data between these components is shown in
ﬁgure 8.1.
The data ﬂow can be summarized as follows:
1. Incoming images are checked against predeﬁned rule sets for eligibility.
2. The Module Manager is informed of eligible images, and queues them for
processing.
3. The original images are stored as normal.
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Figure 8.1: Data are checked against the Logic Engine upon import, and matches
forwarded to external modules for additional processing. The original data are
inserted into the system whether or not they are ﬂagged for processing.
4. Eligible images are processed by the module binary.
5. Results are placed into storage.
8.2.2 Logic engine
Analysis modules can diﬀer in operation for a variety of reasons, including the
modality of the scanned image required (for instance, CT, MRI, PET, etc.), num-
ber of images required (single image, volume stack, temporal series), and body
part scanned, to name but a few. It is necessary, therefore, that the import sys-
tem be able to diﬀerentiate between when a module should be executed. A Logic
Engine is required to perform checks on incoming data in order to decide whether
or not the images meet requirements for additional processing.
A tiered approach is required to deal with availability of modules, creation and
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administering of rule sets (referred to as module protocols), and activation of rule
sets. Rule sets are organized in a logical tree on a per-user basis in the following
conﬁguration:
• User
• Module
• Protocol
• Rule
Additionally, command line parameters can be deﬁned on a per-protocol basis;
these are covered in section 8.2.4.
Rules are of the format:
(Level) Tag Qualifier Value
where Level refers to whether the information is on a study or series level, Tag
is the DICOM header tag to check (for instance, description, modality), Qualifier
is the method of comparison (for instance equals, does not equal, contains), and
Value is the particular value to check for. An example of a rule would be:
(Series) Modality Equals "CT"
Protocol evaluation is performed in two stages, ﬁrst fetching, then checking.
The fetch stage consists of retrieving active module protocols for the current user
for modules which are available. Checking then evaluates each rule against data
included in the DICOM headers of the ﬁles in question.
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Figure 8.2: Users create protocols for modules (A) they are subscribed to. For
each protocol a set of rules (B) is created, and any extra parameters (C) deﬁned.
When a set of rules is fully met by a series, the module is run with the given series
and the associated parameters.
We identiﬁed two principle types of module, User Interface (UI) modules and
Black Box (BB) modules. A User Interface module requires input from a user in
the form of a sort of feedback loop, and can involve processing information multiple
times, for instance where a user modiﬁes parameters after running a module to try
a new conﬁguration. A Black Box module runs one time, and simply accepts a set
of images and some parameters, and produces some results with no interaction.
Placement of the logic engine is dependent on the type of module the system is
required to support.
In the 3DNet implementation, the logic engine is integrated into two compo-
nents of the system. To control execution of black box modules the logic engine
works on the import pipeline. Thus, as new images are being imported they are
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assessed by the logic engine and forwarded for extra processing if the rules are
met. To control the execution of user interface modules the logic engine is inte-
grated into the module launcher, which is in this case a context menu in the study
browser.
Figure 8.2 shows the user interface developed to support creation and editing
of module protocols in 3DNet. The interface automatically populates the list of
modules (Figure 8.2, A) with all modules that the user or user’s organization is
subscribed to. The user is able to create, modify, and delete protocols for each
module, for which they deﬁne a set of rules (Figure 8.2, B) which control when
the module is run. If the module requires it, additional parameters can also be set
per protocol (Figure 8.2, C).
8.2.3 Module management
Probably the largest component in the system, the Analytic Module Manager
(AMM) was conceived to perform a controlling role in module execution and ad-
ministration. The AMM acts as a gateway between the main system, which in-
cludes the logic engine, and the modules. As such, it must maintain a record of
the connection details of every module.
Communication between the module manager and modules is performed over
DICOM association, which allows the module manager to communicate with mod-
ules within the cloud and without. Therefore, the module manager requires knowl-
edge of the AET (Application Entity Title), IP address, and port of all modules
registered with the system. It is not necessary, however, that the module man-
ager have knowledge of additional parameters that modules can accept. These
101
Figure 8.3: The module manager maintains a queue for each module and forwards
data, where it is processed. Results are returned to the module manager, into a
return queue, which inserts them into the main system.
are accepted as an extensible list structure, and placed in an XML ﬁle which is
embedded in the ﬁrst image to send, using the technique described in section 8.2.5.
Concurrent processing is a requirement of the system, and one of the lead-
ing factors in the design of the module manager. It is necessary that it be able
to transmit and receive multiple data sets simultaneously; thus a multi-threaded
approach is desirable. The design proposed uses a collection of queues, one per
module (ﬁgure 8.3). Each module queue is governed by a separate thread, which
controls administration and communication. This approach also takes advantage
of multi-core and multi-processor architecture, where the operating system spreads
process threads across processors.
The module manager maintains records of processing transactions, whether
successful or not, in an attached database. These are to provide an audit trail,
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and to allow for structured payment plans, as well as for bug tracking and ﬁxing.
8.2.4 Module wrapper
Development methodologies can vary greatly between institutions, organizations,
and individuals. As such, there is no standard development platform or method for
creation of medical image analysis modules. Hence, provision of a uniﬁed commu-
nication interface between modules with the main management system becomes
problematic.
In order to address this issue a wrapping element was devised upon which to
mount analysis modules. Such a wrapper has the following requirements:
• Support multiple development languages. The wrapper should be able to
mount modules which are produced in a variety of forms, such as executable
or Java archive.
• DICOM connection support. The wrapper should provide DICOM connec-
tivity for modules which do not support it natively. All communication with
the module manager is performed over DICOM association.
• Customizable to be able to support diﬀerent numbers and order of command
line parameters.
• Scalable instancing to allow the module to be run multiple times simultane-
ously.
• Failure recovery. The module should be able to recover from errors and
continue processing indeﬁnitely.
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A set of standard parameters are deﬁned for analysis modules in order to make
integration simpler. Analysis modules must be able to accept a minimum of three
parameters which describe the location of the input data, a location in which to
place DICOM format output data, and a location in which to place other output
data. Additional parameters are also supported, and this is discussed in section
8.2.3. It is important to consider that a module may produce, or even require,
data in a proprietary format, which is not supported by the DICOM standard.
Section 8.2.5 discusses how binary ﬁle exchange was implemented over DICOM
association.
Instancing is required to allow the module to concurrently process multiple data
sets. The module wrapper maintains a queue for each instance, and distributes
processing jobs according to queue sizes; that is, a new job is added to the shortest
queue, so as to balance the load across all the queues.
Conﬁguration of the module wrapper is achieved through a simple conﬁguration
in the form of an XML ﬁle. This ﬁle contains the DICOM connectivity details
(application entity title, IP address, and port number), the path to the module
executable (or jar, or dll), maximum time the module should take to run, the
number of instances to create, and the order in which the three default parameters
should be supplied (Listing 8.1).
Listing 8.1: Example contents of a module conﬁguration xml ﬁle.
<config >
<aet >MYMODULE </aet >
<ip >127.0.0.1 </ip >
<port >804</port >
<modulepath >C:\ Modules\MyModule.exe </ modulepath >
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<maxrunningtime hours="0" minutes="10" seconds="0"/>
<initialinstances >1</ initialinstances >
<parameters input="0" outputdicom="1" outputcustom="2"/>
</config >
Failure recovery and redundancy In addressing failure recovery we have to
consider two possibilities; ﬁrst, that of a module error causing an inﬁnite loop;
second, that of a software failure which causes the module wrapper to exit unex-
pectedly. In the case of an inﬁnite loop, the wrapper will have no way of knowing
the module is stuck, hence the maximum running time argument in the conﬁgu-
ration. This allows the wrapper to know when a module has been processing for
too long, and the process can be terminated and logged as a failure. To deal with
software failures (crashes) an extra layer of protection is in place in the form of a
module installer service, run automatically on the host machine.
Robustness of service is required in modules being run using the module wrap-
per. This is achieved through a combination of installation of the wrapper as a
Windows service, and an additional service called the Module Installer Service.
The Module Installer Service (MIS) is a unique service which controls the running
and installation of modules wrapped by the module wrapper. Because the module
wrapper requires a command line argument to start correctly, installation and set
up with a view to automatically starting the service is diﬃcult when using the
standard Windows tools. Hence, the MIS was created as a way of automatically
starting instances of the module wrapper.
Installation of module services is simpliﬁed greatly by the inclusion of the MIS,
which is designed to run continuously. The MIS uses a similar xml-based scheme as
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the AMM, scanning a speciﬁc location for ﬁles which it will use to populate its list
of modules. Each conﬁguration ﬁle contains two pieces of information regarding
the installation and running of the module, the service display name (how it will
appear in the list of Windows services) and the path to the conﬁguration ﬁle
described above.
Upon initial execution, the MIS will read each conﬁguration ﬁle and check for
the relevant service. If a service with the given service name does not exist, the MIS
will use the Windows tools to install the service as described in the conﬁguration
ﬁle, and start the service. If the service exists but is not running, the MIS will
restart the service, providing some redundancy against possible failure. Finally, if
a service exists and is running, the MIS will simply ignore the ﬁle. This process
is repeated periodically which both ensures that the services remain running and
that any additional modules added have a new service installed. While providing
an essential part of the 3dnet Medical cloud, the MIS is not required to run on
external hardware for obvious reasons.
8.2.5 Exploiting the DICOM standard for binary file trans-
fer
Situations can occur where binary data transfer is required. Module results, and
prerequisites, are not exclusively of the DICOM ﬁle format. It is not unusual for
proprietary ﬁle formats to be used, and thus a ﬁle exchange method for these is
required. The DICOM standard only supports transfer of DICOM format ﬁles,
and pdf ﬁles encapsulated in a DICOM ﬁle. For reasons previously mentioned, it
was desirable to make use of DICOM associations for data transfer.
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Figure 8.4: Binary data is placed after the original image in the pixel data tag.
Information about the binary data (size, ﬁle name, type) is placed in the ﬁle header
in the form of private tags.
To allow for binary ﬁle exchange over DICOM connection it was required that
the format be exploited somewhat. The important aspect of the ﬁle format is
that the pixel data is encoded last in a ﬁle. It is possible to add extra data to
the end of a ﬁle as is required, and this can all be encoded in the pixel data tag
(ﬁgure 8.4). This does not aﬀect reading of the pixel data, as the pixel data itself
remains unchanged.
These DICOM ﬁles then have a set of supporting private tags embedded to
identify them as carrying extra binary data (and to identify the ﬁle by name,
extension, and size); thus extraction is trivial. To accommodate the varying trans-
fer syntaxes of diﬀerent ﬁles, requiring that the pixel data be either OW (Other
Word) or OB (Other Byte) value representation (VR), byte-padding is sometimes
required. While the OB VR allows the use of bytes, the OW VR requires words
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(in this case, pairs of bytes), and thus the number of bytes present is expected to
be even. In this case, odd-numbered byte arrays are padded with one extra byte.
This added byte has no eﬀect on the pixel data stored using the OB VR, thus it
is performed as a matter of course.
8.2.6 Inter-component communication
Each component in the system is a uniquely identiﬁed DICOM node. This allows
for a single communication system, but also allows communication with external
servers and systems which conform to the DICOM standard, and are open to
accepting DICOM connections.
This allows the invocation of remote analysis modules. If a developer decides
to host their analysis module on their own hardware, the AMM can be conﬁgured
to pass data to it via DICOM networking protocols. Given the nature of the
hosting cloud it is possible, and even likely, that extra computational resources will
become available during the lifetime of the system, either in the form of upgraded
hardware, or more likely in the form of additional servers within the cloud. The
beneﬁt of having such a ﬂexible system is that it can take full advantage of the
extra resources through such remote invocation schemes, without modiﬁcation.
8.2.7 Individualised modelling in the cloud
The clinical relevance of the angiogenic process in human pathology makes an
individualised simulation of angiogenesis an ideal candidate for an analysis module
within the 3DNet Medical imaging system. As the goal of this work is to provide a
basis for an element of personalised medicine, a cloud system like 3DNet Medical
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provides a way of increasing accessibility to the technology, and availability to a
large range of possible data sources.
In real terms, the hardware of the 3DNet cloud is inadequate to support a GPU-
based analysis module for two reasons. First, the cost of even oﬀ the shelf graphics
cards can be a large portion of setup costs, restricting choices. However, more
importantly, a cloud needs to be as reliable as possible, and the life-span of graphics
hardware is typically shorter than that of CPUs. However, the module system was
designed with external as well as internal connections in mind, and so this could
easily be hosted on an external server, wrapped in a DICOM connectivity layer -
indeed, the MWS could happily run on an external server to allow communication
with the AMM, and integration with 3dnet as a whole.
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Chapter 9
Conclusions and Future Work
Probabilistic models of cell motion are an excellent method of simulating the
growth of microvasculature under the given circumstances. The model of cell
motion presented here describes cell motion as movement between grid cells (see
ﬁgure 9.1), whereas previous eﬀorts have limited motion to grid lines, such as the
work of Anderson and Chaplain [3]. The decision to use grid cells instead of lines
allows for cell motion across diagonal elements, which produces smoother transi-
tions across chemical gradients, and more natural curves. This is further enhanced
by the decision to limit the curvature of emerging vascular segments by preventing
endothelial tip cells from doubling back upon themselves.
This approach has many degrees of ﬂexibility. One interpretation of this could
be that the model is uncertain, in need of reﬁnement. However, limiting options
for simulation will only limit the applications of a model. This model seeks to
provide a ﬂexible base for simulating a variety of angiogenic pathologies, enabling
further customisation if required.
Building upon this, the decision to use scan data is an entirely new way of
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Figure 9.1: Previous models have limited motility of cells by constraining motion
to grid lines (left). This model uses grid cells instead, adding an extra degree of
freedom in the form of diagonal motion (right). In three dimensions, this increases
the number of potential movement sites from eight to twenty-seven.
setting up an environment for angiogenic simulations. This technique allows the
simulation of angiogenesis in a considerably more realistic environment than pre-
vious eﬀorts. As opposed to other simulations which have focused on reproducing
the results of in vitro models, this technique was designed with the aim of repro-
ducing in vivo growth patterns in silico, which is key in closing the gap between
simulations and reality.
The structure built from the scans is aligned along a regular grid, which appears
naïve given the irregular, and in fact continuous, environment the body exists in,
however this is an assumption made for two very important reasons. Regarding the
motion of the endothelial cells themselves, this provides a computationally eﬃcient
way of organising the simulated motion and ﬁts in neatly with other elements of
the simulation. In respect to the images used and the physical structure of the
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vascular network, the truth is that an exact cell-by-cell map of even a small piece
of vasculature is virtually impossible to acquire. In this respect, the simulation
makes an assumption about the regularity of cells in the endothelium, which is well
documented, and what results is a best guess to describe the starting conditions
of the vasculature, which in reality is not that far removed from the truth.
Due to the nature of the system, it being a three-dimensional environment, it
takes large amounts of memory to set up the simulation environment. As such,
it was a requirement at the time that the functional units were allocated in main
memory. This could theoretically be moved into graphics memory given suﬃcient
hardware capabilities. Current top-of-the-range graphics cards are available with
as much as twelve gigabytes of memory, providing adequate capability for storage
of the entire simulation environment.
Diﬀusion and ﬂuid ﬂow are both integral to the function of human vasculature.
To obtain any level of realism, the fundamentals of the function of the vascular
system need to be understood and correctly implemented. Incorporating elements
such as these into a simulation of vessel growth and function is essential in achieving
a degree of realism which provides and meaningful representation of the systems
at work in the human body.
The graph-based method of ﬂow calculations oﬀers an eﬃcient way of solving a
complex system. A considerable sacriﬁce in terms of accuracy is the treatment of
blood as a uniform ﬂuid, which it is not. It is arguable that a more realistic solution
should be used, however it is important to remember that the goal of this work
is to ﬁnd an acceptable balance between speed and realism. While, as discussed
previously, a Lattice-Boltzmann approach oﬀers much higher spacial resolution,
the assumed increase in realism is lacking due to its treatment of blood as a uni-
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Size of Grid CPU GPU
64 0.49s 0.16s
96 1.99s 0.63s
128 10.88s 1.527s
160 17.16s 3.01
192 37.87s 5.27s
Table 9.1: Comparing the execution times of a diﬀusion solver in CPU- and GPU-
based solutions. The GPU produces markedly faster execution times, even when
the number of cores available is exceeded.
form ﬂuid. As such, the additional increased demand in power and time required
oﬀers little in the way of beneﬁt. Conversely, systems which seek to simulate ery-
throcite movement within vessels will indeed oﬀer more realistic results, however
the increased complexity of such a system makes it undesirable here, especially
considering the goal of increasing simulation sizes.
An issue which arises with this system is the need to regularly transfer data
between graphics memory and main memory. Typically, in applications that make
heavy use of graphics hardware, this is minimised wherever possible as it is a
performance bottleneck.
When running like-for-like simulations on the GPU and on the CPU, it is easy
to see that the GPU solution is preferable. Table 9.1 shows the diﬀerence in execu-
tion times for 100 iterations over a diﬀerent sizes of grid of the diﬀusion algorithm.
The increasing simulation times for the GPU may seem counter-intuitive, however
this is due to a limitation in the hardware used. Three-dimensional grids of thread
blocks are available in later versions of CUDA, however the hardware in use did
not support this. To maintain the three-dimensional analogue, three-dimensional
threadblocks were used in a two-dimensional grid. Thus, the simulation domain is
split into thick slices, which are processed sequentially one section after another.
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Due to the nature of the Gauss-Seidel method for solving the equation, this split
becomes unimportant as it simply uses the latest values available.
When the concept of using scan data for instantiating the simulation environ-
ment was initially conceived, it was with the goal of mimicking the ﬁne details of
the scan data itself. The ﬁnest vessels would be removed, a result which tended to
occur anyway through the use of thresholding, and simulations results would be
directly compared to see if the same original vessel pattern was regrown. However,
due to the stochastic nature of the simulation process, and early simulation results,
it became apparent that this was not a feasible goal to have. A more appropriate
method of comparison was thus sought.
To this end, a measure of tortuosity, or deviation from a straight path, was
used. This can easily be measured by comparing the end to end length of a vessel
segment, i.e. the straight-line distance between the start and end nodes, with the
actual length of the vessel segment generated.
When analysing scan images, processing is in three stages: ﬁrst, the images
are converted to binary images; second the resulting binary images are reduced to
a skeleton using a thinning system; ﬁnally the skeleton is analysed to ﬁnd node
points and vessel lengths. This analysis was performed using the free tool ImageJ.
Analysis of generated vasculature was somewhat simpler, as it was stored in terms
of geometric information, and not as images.
There will always be outliers in a simulation which is guided, at least in part,
by random motion. Figure 9.3 compares the distributions of real scan data with
simulated results: the best results were obtained using a chemotactic bias of 0.6.
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9.1 Future work
This work seeks to provide a method for simulating a biological phenomenon with
immediate clinical relevance in a realistic manner in real time. An important goal,
therefore, was to ﬁnd a balance between the requirements of realism, requirements
in terms of power, and completing the simulation within a reasonable time frame.
The method presented here is entirely scalable, limited only by hardware fac-
tors, notably memory and processor speed. As such, there is no technical limit
to the size of the simulation, however there are practical limits to how useful an
enormous simulation could be. An angiogenesis simulation across the entire body,
for example, would be of little use in studying the eﬀect of a tumor site in one
isolated location, as well as being infeasible in terms of memory, processor and
graphics card requirements.
Current simulation sizes are between 1 - 2 millimeters cubed, which are a
useful starting point for simulation eﬀorts, but not of much use in terms of clinical
relevance. The combination of parallel processing and CPU techniques is a useful
way of spreading the load across available hardware, however, and bearing in mind
current trends, increased simulation sizes are far from impossible. Running this
simulation with a grid size of two millimetres per side takes approximately two
point four gigabytes of memory. Of course, the memory requirements rise at a
cubic rate, and can be obtained using an assumption of three hundred megabytes
per cubic millimetre.
Even conventional home-user systems have gigabytes of memory available, and
high-end workstation graphics cards oﬀer as much as twelve gigabytes of video
memory, so it is not outside the realms of possibility that such simulations will
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soon become feasible for sizes measured in centimetres, not millimetres.
Simulating angiogenesis is not a new subject, although it is one of continuing
research. However, this is the ﬁrst time graphics hardware has been used to accel-
erate the simulation environment. The use of parallel processing in this context is
key in balancing the resource requirements. By moving the mathematically heavy
ﬂuid dynamics equations to the graphics hardware, the CPU is freed to concentrate
resources on the cellular motion and supporting functions, such as graph building.
Coding for the GPU and CPU uses two distinct models of programming. The
parallel programming model as described in chapter 6 is not suited to the kind
of individualised decision making process of a Cellular Potts Model. An object
oriented approach to coding is much more ﬂexible. The ability to create member
variables for each object means that accessing personal data is much easier than
with a parallel model where memory is shared and must be speciﬁcally indexed
to be accessed. To emulate this kind of functionality on the GPU would require
creating a buﬀer for each variable and populating via an index representing the
identity of each “object”. This has two distinct disadvantages.
Allocating memory dynamically during programme execution on the graphics
card is undesirable, as it requires the reallocation of entire buﬀers, followed by
copying memory, which is a costly procedure in terms of time. For the pressure
system, which changes as the vascular network grows, buﬀers are doubled when
more space is required in an eﬀort to reduce the frequency of rebuﬀering data (up
to a point - when the buﬀer exceeds a certain size, further rebuﬀers are of a ﬁxed
size to reduce the likelihood of running out of memory).
In addition to this, accessing data which might belong to another “object” could
feasibly cause conﬂicts in access. In an object oriented model this is much safer
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with the use of accessor methods which provide a safe way of retrieving information
from other objects.
As an additional consideration, it is worth bearing in mind the increased de-
velopment cost versus the potential gains of having an all-GPU solution. Doing
so negates the beneﬁts of having a centralised unit which distributes information
if all subsystems reside on the graphics card, but the ﬂexibility of such a modular
system is lost.
Aside from size, a major barrier at present to the use of the techniques out-
lined here in a predictive capacity lies in the limitations of scanning technology
available. The images used were microCT scans of resin casts, which provide a
very good spacial resolution. Unfortunately, this technique is inappropriate for hu-
man use. Scanner technology is ﬁeld of continuing research, however, and spacial
resolutions similar to those of microCT scanners are sure to be available in less
invasive methods (such as MRI) before too long.
9.2 Tissue engineering
The need for studying microvasculature is not limited to clinical diagnosis of dis-
eases. A major diﬃculty in engineering tissues in vitro is engineering vascularised
tissues. Any tissue that is more than a few hundred microns thick needs a proper
vascular system because every cell in a tissue needs to be close enough to cap-
illaries to absorb the oxygen and nutrients. This is why skin and cartilage were
among the ﬁrst to be ready for human testing, since they do not require extensive
internal vasculature. An engineered tissue implant will have to connect quickly
with the host vascular system. Creating appropriate environments/scaﬀolds to
117
promote vascular growth, especially those that mimic vasculatures in real tissues,
and imaging of this growth in vivo are therefore also important aspects of tissue
engineering. However, vasculatures engineered in vitro are at present governed
by, at best, information gathered from the literature or, at worst, by uninformed
trial and error. They lack the functional properties of real vasculatures, espe-
cially microvessels or capillary beds. Though there has been active research using
mathematical models of angiogenesis to generate vascular structures , these cannot
match the microvascular patterns in real tissues.
In their 2011 paper, Novosel et al. [7] stated that the key challenge in tissue
engineering is vascularisation . Current methods for tissue engineering involve
growing tissue in an oxygenated solution, in order to simulate perfusion by blood
vessels. This, however, means the tissue is not grown with a network of blood ves-
sels of its own. One application of simulations of angiogenesis would be to design
blood vessel scaﬀolds which not only successfully perfuse a region of tissue, but also
mimic the natural formation of vascular networks. An individual-based model for
angiogenesis means that the network can be tailored to any domain speciﬁed. Re-
cently, Miller et al [20] described a modiﬁed three-dimensional printing technique
for creating pre-vascularised scaﬀolds for tissue engineering, which combined with
a realistic generation method for vascular networks could aid the advancement of
tissue engineering by allowing the growth of pre-vascularized structures.
9.3 Cloud computing
Future research will be to go back to where this PhD project started. The project
was sponsored by an EPSRC Industrial Case Award, working with Biotronics3D
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on medical imaging on the Cloud.
Continuing the work here naturally leads to the concept of developing the
simulation in such a capacity as to be incorporated In as a module in the 3DNet
Medical cloud. In developing this solution as a module for the cloud certain ending
conditions need to be speciﬁed. These could, realistically, be temporal, i.e. setting
a limit for simulation time, or cell-based, i.e. when there are no more cells eligible
for migration the simulation is over. Providing both as optional parameters would
give researchers a ﬂexible way of ensuring that simulation times do not get out of
hand.
There has been interest in the eﬀectiveness of anti-angiogenic therapies in the
treatment of cancer. Some work has been performed in this area which shows
that anti-angiogenics, whilst decreasing the active blood vessel network around a
tumour, impede the delivery of other treatments such as chemotherapy. This is a
promising area of research, and an ideal candidate for future developments in this
system. This would incorporate additional elements of the pathology, starting with
the introduction of growth factor producing tumour cells, which would then grow
based upon the delivery of oxygen through induced vessel growth, or demonstrating
how this is impeded by the introduction of anti-angiogenic substances.
9.4 A more general scheme for modular develop-
ment
Building on the current work, one could assume the goal of designing an entirely
modular system and toolkit for the development of medical simulations. The work
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here already describes a basis for how such a system can be achieved, combining
both CPU and GPU techniques towards the creation of a single uniﬁed system.
While image processing and visualisation eﬀorts have become uniﬁed over the
years, there is still a considerable distance between medical simulation developers
and researchers. The Biotronics3D solution is a step in the right direction, en-
couraging developers to share their work on a uniﬁed platform, but in order to
improve research eﬀorts in simulation such a system is still lacking. While, as
previously discussed, visualisation and imaging toolkits are widely available, there
is a distinct lack of any such framework for simulations, making this avenue ideal
for future work.
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Figure 9.2: Increasing the chemotactic bias produces straighter vessels, whereas
decreasing produces more random, tortuous results. Shown here are results with
bias values of 0.2, 0.4, 0.6, and 0.8, in descending order. Identifying factors which
aﬀect the endothelial cell’s response to the chemical gradient could be beneﬁcial
in early diagnosis of disease.
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Figure 9.3: The distribution of actual length divided by end to end length. First
is the distribution from scan data; second is using a low chemotactic bias; bottom
uses a high chemotactic bias.
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Figure 9.4: A complete simulation shown from four distinct view points. New ves-
sels are coloured based on the blood pressure, solved using the algorithm described
in 6.
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Figure 9.5: By creating a stack of images to reﬂect a manufactured tube and
initialising a gradient of growth factor, this method can be used to ﬁll an arbitrary
space with vasculature. Changing the parameters (decreasing chemotactic bias
from left to right) produces diﬀerent densities of vessels.
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